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1Glossary
ACSF- Artificial Cerebrospinal Fluid
AHS- Ammon Horn Sclerosis
BAC-Bacterial Artificial Chromosome
BrdU Bromodeoxyuridine
BSA-Bovine Serum Albumin
CA -Cornu Ammonis
CNS-Central Nervous System
Cx -Connexin
DG-Dentate Gyrus
DKO-Double Knock Out
ECFP- Enhanced Cyan Fluorescent Protein
EGFP- Enhanced Green Fluorescent Protein
EYFP- Enhanced Yellow Fluorescent Protein
EEG- Electroencephalogram
floxed-flanked by loxP sites
GFAP-Glial fibrillary acidic protein
GCD -Granule Cell Dispersion
GluT-Glutamate Transporter
GluR-Glutamate Receptor
KI-Knock In
KO-Knock Out
M-Molar
mg-milligram
ml-millilitre
NGS-Normal Goat Serum
CONTENTS 2
PBS-Phosphate buffered saline
PCR-Polymerase chain reaction
PFA-Paraformaldehide
RT-Room Temperature
SGZ-subgranular zone
SE-Status Epilepticus
SVZ-subventricular zone
VPL-ventral posterolateral thalamic nucleus
VPM-ventral posteromedial thalamic nucleus
WT-wild type
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Introduction
1.1 Glial Cells in the Central Nervous System
Glial cells are non neuronal cells in the Central Nervous System (CNS). The term
glia (from Greek glue), was a translation of the term ”Nervenkitt” introduced
by Virchow in 1858. By his opinion, glia is connective tissue completely devoid
of any cellular elements (Verkhratsky & Butt, 2007). Later on it was shown, by
different anatomists, that glia consists of different types of cells – astrocytes,
oligodendrocytes, microglia, and recently, a different cell type was described, the
so-called polydendrocytes (Nishiyama et al., 2009), or NG2 glia (Peters, 2004).
The proportion of glial cells in the cerebral cortex increases with increasing
complexity of the brain (Bass et al., 1971). The lineage relationship between
different macroglial cell types was studied by Liu et al. 2002 and reviewed by
Nishiyama et al. 2009; a summary is shown in Fig1.1. Until the eighties of the
twentieth century, only a function in mechanical stability was attributed to glia,
but since then, this view has changed. In fact, it was recognized that glia plays
a crucial role in brain functioning. A great variety of ion channels (Verkhratsky
& Steinha¨user, 2000) are expressed in glial cells including glutamatergic and
non-glutamatergic receptors (de Jesus Domingues et al., 2010; Verkhratsky &
Kirchhoff, 2007). NG2 glial cells form synapses with neurons (Bergles et al.,
2000; Jabs et al., 2005). Astrocytes are involved in neurogenesis (Pinto & Go¨tz,
2007), and they influence synaptic transmission (Volterra & Steinha¨user, 2004)
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and neuronal excitability by spatial buffering of K+ (Kofuji & Newman, 2004).
Fig. 1.1: Hypothetical lineage relationship between polydendrocytes (or NG2 cells) and
other macroglial cells. The cellular source of each mature cell type is shown. The thickness
of the arrows represents the relative contribution of the precursor population. Most polyden-
drocytes arise from the medial ganglionic eminence (MGE) and the anterior entopeduncular
region (AEP), with a minor contribution from radial glia. Polydendrocytes give rise to
oligodendrocytes and a subpopulation of protoplasmic astrocytes in the grey matter but do
not give rise to white matter astrocytes. Other sources of astrocytes include cells in the
subventricular zone (SVZ) and radial glia. The neuronal fate of polydendrocytes is still
debated (as indicated by the dotted line). Although most neurons arise from neuroepithelial
cells in the ventricular zone, radial glia and cells in the SVZ, a small number of neurons in
the piriform cortex might be generated from NG2 positive cells in the adult brain (modified
from Nishiyama et al. 2009).
1.1.1 Astrocytes
Astrocytes are the most abundant cell type in the CNS. The term“astrocyte”
is an umbrella term which covers different cell types in the brain. According to
Reichenbach and Wolburg (Reichenbach & Wolburg, 2005) eleven main types
of astroglia exist (Fig 1.2): protoplasmic astrocytes, velate astrocytes, fibrous
astrocytes, perivascular astrocytes, Bergmann glia, radial astrocytes, Mu¨ller
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Fig. 1.2: Morphological types of astrocytes. Ia – pial tanycyte; Ib – vascular tanycyte;
II– radial astrocyte (Bergmann glial cell); III – marginal astrocyte; IV – protoplasmic
astrocyte; V – velate astrocyte; VI – fibrous astrocyte; VII – perivascular astrocyte; VIII –
interlaminar astrocyte; IX – immature astrocyte; X – ependymocyte; XI – choroid plexus
cell. (From:Reichenbach & Wolburg 2005)
glia, marginal glia and ependymal glia. All these cell types have different
morphology - but have two common features - the first feature is the formation
of specific processes – endfeet contacting the basal lamina of blood vessels
and/or the pia mater or the vitreous body of the eye. The second feature is
coupling by gap junctions. Astrocytes are involved in many brain functions,
and influence neuronal activity in different ways: astrocytes guide neurites
and are essential for synapse formation (Ullian et al., 2001; Slezak & Pfrieger,
2003). Astrocytes are implicated in the glutamate–glutamine cycle (glutamate
is the main excitatory neurotransmitter in the CNS). Glutamate removal from
CHAPTER 1. Introduction 6
the synaptic cleft is critical for normal synaptic function. Astrocytes remove
up to 80 % of glutamate from the synaptic cleft (Verkhratsky & Butt, 2007)
mostly by the glutamate transporter GLT-1 (the human homologue is called
EAAT2 Haugeto et al. 1996; Furness et al. 2008). After uptake of glutamate
into astrocytes, it is converted to glutamine mainly by the astrocyte specific
enzyme Glutamine Synthetase (GS; Liaw et al. 1995). Glutamine is transported
into the extracellular space where it is taken up by neurons and again converted
to glutamate (Bro¨er & Brookes, 2001). Glutamate could be, also, released from
astrocytes using different mechanisms (Kimelberg et al., 1990; Szatkowski et al.,
1990; Duan et al., 2003). Glutamate release from astrocytes may play a role
in the astrocytic modulation of neuronal currents and synaptic transmission
(Araque et al., 1998; Kang et al., 1998). Another important feature of astrocytes
is the ability to regulate blood flow. Changes in neuronal activity cause an
elevation of the calcium level in astrocytes which in turn change the diameter
of the brain arterioles (reviewed by Iadecola & Nedergaard 2007; Jakovcevic
& Harder 2007). Astrocytes are important for blood brain barrier (BBB)
formation and maintenance. The BBB is constituted by endothelial cells which
form tight junctions and are surrounded by astrocytic endfeet. Physical contact
between astrocytes and endothelial cells is important for the formation of
tight junctions. In the absence of astrocytes formation of tight junctions by
endothelial cells is impaired (Isobe et al., 1996) . The Glial Fibrillary Acidic
Protein (GFAP), an astrocytic intermediate filament seems to be required for
this process, since a similar effect was observed in GFAP KO mice (Pekny et al.,
1998). Some astrocytic functions are closely related to gap junctional coupling.
These functions are reviewed in chapter 1.2.3.
Astrocytic markers
GFAP is an intermediate filament protein important for the cytoarchi-
tectural stability of the cell (Liedtke et al., 1998), and its expression increases
during reactive gliosis that occurs as a response to brain injury and disease
(Eddleston & Mucke 1993, reviewed by Middeldorp & Hol 2011; Eng et al.
2000). GFAP is considered as a specific marker for astroglia (Ludwin et al.,
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1976; Bignami et al., 1972) and cells from the astrocytic lineage. GFAP is
expressed by mature astrocytes, starting from the stage of myelination (P5
in rats Dahl 1981) and by radial glia like cells (Alvarez-Buylla et al., 2002;
Shapiro et al., 2005). Astrocytes in cortical layers III and IV do not express
GFAP, except for cells clustering around blood vessels (Stichel et al., 1991).
S100β is a calcium binding protein involved in the regulation of astrocytic
proliferation and activation (Brozzi et al., 2009). S100β is expressed mainly in
astrocytes (Boyes et al., 1986; Ogata & Kosaka, 2002), results demonstrating
expression of S100β in NG2 cells are controversial (see 1.1.1.1).
Glutamine Synthetase The main function of GS is ATP dependent
conversion of glutamate to glutamine (Liaw et al., 1995). GS is expressed
predominantly by astrocytes (Norenberg & Martinez-Hernandez, 1979), but
its expression was also reported in a fraction of gray matter oligodendrocytes
(Miyake & Kitamura, 1992).
1.1.1.1 NG2 Cells
NG2 cells are also called polydendrocytes (Nishiyama et al., 2002), synantocytes
(Butt et al., 2005), NG2 positive cells (Nishiyama, 2001) or GluR cells (Wallraff
et al., 2004) and are a newly identified type of glia. This type of glia is charac-
terized by expression of platelet-derived growth factor receptor α (PDGFRα)
and NG2 (an integral membrane chondroitin sulphate proteoglycan). In white
matter the NG2 positive cells give rise to oligodendrocytes, whereas in the
gray matter the NG2 positive cells are mostly mature postmitotic cells (Dimou
et al., 2008).
Reports about S100β expression in NG2 cells are contradictory. From
no overlap between S100β and NG2 (Nishiyama et al., 1996) to almost 100%
overlap between S100β and NG2 (Deloulme et al., 2004) were reported. Utilizing
mice expressing EYFP under control of all regulatory elements of the NG2
gene, Karram and colleagues observed 20 % of colocalization of EYFP with
S100β in juvenile mice and 31% in adult mice (Karram et al., 2008). In cortex
of PDGFRαCreERT2 mice 10 % YFP positive cells were also S100β positive
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(Rivers et al., 2008). From all this data we can conclude that only a subset of
NG2 glia is also S100β positive.
1.1.2 Microglia
Microglial cells are the resident macrophages of the CNS. They are derived from
fetal macrophages which invade the brain during development (Perry et al.,
1985). The proportion of microglia in the adult mouse brain varies between 5%
in the corpus callosum and cortex and 12% in the substantia nigra (Lawson
et al., 1990). The number of microglial cells increases with age (Vaughan
& Peters, 1974). In adult brain, microglia exists in three different forms:
1) ramified microglia, 2) activated microglia and 3) reactive (phagocytotic)
microglia. Ramified (resting) microglia is the most prominent type of this cell
population in the adult brain. It is characterized by long thin processes and a
small cell body. In the case of brain damage or inflammation, microglial cells
change their morphology to swollen ramified microglia with thick processes and
a bigger cell body. This state is called activated microglia. Stronger damage
to the brain, for example stroke, causes transformation of activated or resting
microglia to a round-shaped, reactive phagocytic form (reviewed by Streit et al.
1988; Davis et al. 1994; Hanisch & Kettenmann 2007).
Microglial markers
Iba-1 (ionized calcium-binding adapter molecule 1) is expressed in the
monocytic lineage. In the brain Iba-1, is expressed predominantly by microglia
(Imai et al., 1996; Hirasawa et al., 2005).
Lectins such as GSA, GS-1, RCA, WGA, and ConA, bind to specific sugar
groups of the cell walls. Lectins stain both ramified and activated microglia.
In addition, lectins stain endothelial cells (Streit, 1990; Colton et al., 1992).
CD11b/18 (CD11b in rat, CD18 in mouse) is a complement receptor 3
(CR3) and belongs to the family of β-2 integrins (Akiyama & McGeer, 1990).
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CD11b/18 is expressed constitutively by macrophages and microglia (Akiyama
& McGeer, 1990).
CD68 (macrosialin in mouse, ED-1 in rat) plays a role in phagocytosis
and Low Density Lipoprotein (LDL) binding. CD68 is expressed at low level in
resting microglia and at high level in activated microglia (Slepko & Levi, 1996;
Kingham et al., 1999).
1.1.2.1 Oligodendrocytes
Oligodendrocytes are the cells that produce the myelin sheath surrounding axon
in the central nervous system. Oligodendrocytes are classified into four different
subtypes according to the size of their somata, the number and orientation of
their processes and the diameter of associated axons (Butt, 2005). Commonly
used oligodendrocytic markers are 2’,3’-cyclic nucleotide 3’-phosphodiesterase
(CNPase, McEwan 1996) and the oligodendrocyte specific transcriptional factor
OLIG2 (Yokoo et al., 2004).
1.2 Astrocytic Connexins
1.2.1 Gap Junctions
Gap junctions are channels connecting the cytoplasm of two adjacent cells.
These channels consist of two hemichannels or connexons (one for each cell).
Each connexon is built of six connexins subunits (Makowski et al., 1977). The
connexin protein structure was predicted by hydropathy plots and confirmed
by immunohistochemistry and proteolytic cleavage (Zimmer et al., 1987; Milks
et al., 1988; Goodenough et al., 1988; Yancey et al., 1989). Connexin proteins
have four transmembrane domains, two extracellular domains, a cytoplasmic N
and C terminus and one cytoplasmic loop (see Fig. 1.3). The internal diameter
of the gap junction pore is 10 to 14 angstroms and permeable for molecules up
to 1200 Dalton (Simpson et al., 1977). Small RNAs, glucose, cAMP, amino
acids, calcium ions (Sa´ez et al., 1989) and many other molecules (reviewed in
Harris 2001) can pass through gap junctions. A few thousand of single channels
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group together to form a plaque (Caspar et al., 1977; Hoh et al., 1993). The
connexin gene family includes 21 genes in the human genome and 20 in the
mouse genome (reviewed in So¨hl & Willecke 2003; Beyer & Berthoud 2009).
Connexins are named according to their molecular weight, i.e. a connexin
protein with the molecular weight of 43 kDa is called connexin 43 (Beyer et al.,
1987).
1.2.2 Astrocytic gap junctions
Electrophysiological studies of glial cells showed that they are electrically
coupled (Kuffler et al., 1966), and that the structures connecting the cells
are gap junctions (Brightman & Reese, 1969). The first type of gap junction
identified in astrocytes was Cx43 (Dermietzel et al., 1989; Yamamoto et al.,
1990a,b). Later, the expression of two additional astrocytic connexins – Cx30
(Nagy et al., 1999; Rash et al., 2001) and Cx26 (Nagy et al., 2001, 2011) was
shown. The expression of Cx40, Cx45 and Cx46 was observed in cultured
astrocytes from newborn Cx43 knock out mice (Dermietzel et al., 2000), but
their presence in astroglia of the intact brain and their possible physiological
function remains unclear.
1.2.3 Cx43 and Cx30
Connexins 43 and 30 are the main astrocytic connexins in CNS. In Cx43 KO
mice astrocytic gap junctional coupling measured by spread of tracer, was
reduced by 50% (Theis et al., 2003). In Cx43 Cx30 DKO mice, interastrocytic
gap junctional coupling was completely lacking (Wallraff et al., 2006).
1.2.4 Functions of the astrocytic gap junctions
1.2.4.1 Spatial buffering of K+
As a result of neuronal activity, both normal and pathological, extracellular K+
is elevated (Sykova´, 1981; Sykova´ & Chva´tal, 1993; Heinemann & Lux, 1977).
High concentrations of K+ impairs neuronal excitability. Thus, for normal
neuronal function the excess of extracellular K+ must be removed. The main
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Fig. 1.3: Gap Junction Structure. A. A gap-junction channel is actually a pair of hemichan-
nels, one in each opposite cell, that match up in the gap junction through homophilic
interactions. The channel thus connects the cytoplasm of the two cells and provides a direct
means of flow between the cells. This bridging of the cells is facilitated by a narrowing of the
normal intercellular space (20 nm) to only 3.5 nm at the gap junction. Electron micrograph:
Each channel appears hexagonal in outline. Magnification Ö 307,800. B. Each hemichannel,
or connexon, is made up of six identical protein subunits called connexins. Each connexin is
about 7.5 nm long and spans the cell membrane. A single connexin is thought to have four
membrane-spanning regions. C. The connexins are arranged in such a way that a pore is
formed in the center of the structure. The resulting connexon, with an overall diameter of
approximately 1.5-2 nm, has a characteristic hexagonal outline. The pore is opened when the
subunits rotate about 0.9 nm at the cytoplasmic base in a clockwise direction.(from Kandel
et al. 2000)
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mechanism of K+ removal from the extracellular space is K+ spatial buffering
(Kofuji & Newman, 2004; Orkand et al., 1966). In the Mu¨ller cells of the retina,
this mechanism is termed K+ siphoning (Newman et al., 1984). In this mecha-
nism K+ is transferred from a place with high extracellular concentration to a
place with low extracellular concentration through the astrocytic syncytium.
The inwardly rectifying K+ channels Kir4.1 are responsible for most of the K+
uptake by astrocytes (Djukic et al., 2007). Kir4.1 K+ localized predominantly
on the astrocytic processes surrounding synapses, and astrocytic endfeet wrap-
ping blood vessels (Higashi et al., 2001; Neusch et al., 2006), and due to its
localization may serve as a main efflux of K+ out of astrocytic syncytium (Butt
& Kalsi, 2006). Kir4.1 is highly colocalized with the water transport protein
aquaporin4 (Nagelhus et al., 1999). Efflux of K+ from the astrocytes to the
blood is followed by massive water efflux (reviewed in Rash 2010; Simard &
Nedergaard 2004). For the mechanism of K+ buffering astrocytic gap junctional
coupling is necessary. Animals with genetic deletion of Cx30 and Cx43 show
impaired spatial K+ buffering and increased epileptiform activity (Wallraff
et al., 2006).
1.2.4.2 Transport of glucose and metabolites
Astrocytes, due to their position between blood vessels and neurons, can
transfer glucose and metabolites to the neurons from the blood. Currently, two
models of the mechanism of glucose and metabolites transfer to the neurons are
proposed (reviewed in Barros & Deitmer 2010). According to the first model,
astrocytes transfer metabolites to neurons, neurons metabolize it and release
lactate (i.e. neurons are involved only in the anaerobic stage of glycolysis),
which is absorbed by astrocytes and partially metabolized, partially transfered
to the blood flow. According to the second model (astrocyte-to-neuron-lactate
shuttle hypothesis, ANLSH, Pellerin & Magistretti 1994), astrocytes take up
the glucose and metabolize it to lactate, then the lactate is transferred to
neurons and metabolized by them (i.e. neurons are involved only in the aerobic
stage of glycolysis). To supply metabolites effectively, astrocytes have to form
a syncytium coupled by gap junctions. Transfer of glucose from the blood flow
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is completely absent in Cx30/Cx43 double KO mice (Rouach et al., 2008).
1.2.4.3 The role of Cx30 and Cx43 in neurogenesis
Neurogenesis is a process of the generation of neurons from stem cells. Until
the eighties of the twentieth century, despite of some reports (Altman & Das,
1967, 1965), it was widely accepted, that neurogenesis occurs only during
developmental stages of ontogenesis. However recent studies clearly showed
that neurogenesis occurs likewise in the adult brain (Goldman & Nottebohm,
1983; Eriksson et al., 1998; Kempermann et al., 1997). Adult neurogenesis
occurs mainly in two places in the brain: in the Subgranular Zone (SGZ) of
the dentate gyrus and in the Subventricular Zone (SVZ) of the lateral ventricle
(Ming & Song, 2005). The neuronal progenitors in the adult brain are called
radial glia-like cells (other names: type I progenitor cells, radial astrocytes,
vertical astrocytes; Ehninger & Kempermann, 2008; von Bohlen Und Halbach,
2007; Kempermann et al., 2004), which belong to the neuroepithelial → radial
glia → astrocyte lineage. Radial glia-like cells express the astrocytic markers
GFAP and nestin, but do not express S100β (von Bohlen Und Halbach, 2007;
Ehninger & Kempermann, 2008). These cells give rise to both neurons and glia
(Alvarez-Buylla et al., 2001). Type I progenitor cells divide asymmetrically
and give rise to type IIa cells, which are negative for the immature neuronal
marker doublecortin (DCX). They also generate type IIb cells which are DCX-
positive and Prox-1 positive - progenitor cells (Kronenberg et al., 2003; Steiner
et al., 2008; Ehninger & Kempermann, 2008). Both these cell types are GFAP
negative and nestin positive, and they are proliferative. Type II progenitor cells
give rise to nestin negative and DCX-positive, proliferating type III progenitor
cells (Kronenberg et al., 2003). The next two stages of adult neurogenesis are:
immature neurons which are expressing the Ca2+-binding protein calretinin
and DCX and mature granule neurons which are expressing the Ca2+-binding
protein calbindin (Brandt et al., 2003; Kempermann et al., 2004). Cx43 and
Cx30 were shown to be crucial for adult neurogenesis. Mice lacking both Cx43
and Cx30 show a low proliferation rate in the SGZ and a reduction in the
number of granule cells in the dentate gyrus (Kunze et al., 2009).
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1.3 The Cre/LoxP system
The Cre/LoxP system is the main tool for mouse genome manipulation (Nagy,
2000). The Cre recombinase is a site specific recombinase from the E.Coli
bacteriophage P1. It is used by the bacteriophage for incorporation of the
phage genome into the E.Coli genome. No additional proteins are necessary for
Cre recombinase action (Sauer & Henderson, 1988). The Cre recombinase binds
to 34bp long recognition sites which are called LoxP sites. The DNA flanked by
LoxP sequences is called “floxed” DNA. Depending on the orientation of LoxP
sites a floxed part of DNA could be inverted or excised. Two monomers of Cre
bind to a LoxP site (one to each strand of the DNA) and form a dimer. Two
Cre dimers from two LoxP sites form a tetramer, and recombination occurs
(Guo et al., 1997). As result of the recombination, the DNA between two
directly oriented LoxP sites is irreversibly excised (Figure 1.4).
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Fig. 1.4: Cre mediated DNA recombination. (a) Cre expression is driven by an exogenous
promoter of choice, enters the cell nucleus and binds to LoxP sites flanking a target gene.
(b) The DNA surrounding the target gene undergoes a conformational change to bring the
two LoxP sites into close proximity where a synaptonemal complex is formed. DNA strand
exchange occurs at the sites of homology leading to the excision of the target gene (c) and
the presence of a single LoxP site (generated from two half-sites) at the original genomic
location (modified from Smith, 2011)
.
By expression of Cre recombinase under a cell-type specific promoter,
deletion of a gene can occur in a specific cell type (Gu et al., 1994). A floxed
coding region could be followed by a reporter gene. As a result of the gene
deletion, the reporter gene is expressed instead of the deleted gene (Theis et al.,
2001b). For Cre activation at a specific time point, a fusion protein of the Cre
recombinase and the ligand binding domain of a mutated estrogen receptor
(CreERT) was generated (Metzger et al., 1995; Feil et al., 1996). The modified
receptor is activated by tamoxifen and 4-hydroxytamoxifen (4-OHT), but not by
estradiol itself. CreERT is located in the cytoplasm, where it is bound to heat
shock proteins (Picard, 1994; Mattioni et al., 1994). After 4-OHT application,
the CreERT- heat shock protein complex is dissociated, CreERT is translocated
to the nucleus where it induces recombination (Hayashi & McMahon, 2002).
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1.4 Anatomy and functions of the mouse brain
regions investigated in this study
1.4.1 The Hippocampus
The hippocampal formation is a part of the limbic system responsible for
explicit memories (declarative memory- the ability to recall facts and events),
and for spatial memory (Martin, 2003). The hippocampal formation consists of
the Ammon’s horn (or Cornu Ammonis), the dentate gyrus, and the subiculum.
Each structure consists of several regions(Fig. 1.5 A).
1.4.1.1 Anatomy of the hippocampus
Cornu Ammonis (CA) is differentiated into regions three regions: CA1, CA2,
and CA3. CA is also structured to clearly separated layers. Layers of CA:
Stratum pyramidale. The layer of the Cornu Ammonis contains the cell bodies
of the pyramidal neurons. The stratum oriens contains the basal dendrites of
the pyramidal cells, and a variety of interneurons. This layer is located just
above pyramidal cell layer, and below the corpus callosum. A very thin layer
below the stratum pyramidale in the CA3 region contain mossy fibers and is
named stratum lucidum.The stratum radiatum is located below the stratum
pyramidale in the CA1 and CA2 regions and below the stratum lucidum in the
CA3 region. This layer contains the Schaffer collaterals (projections from CA3
to CA1) as well as other commisural projections, dendrites of the pyramidal
cells and interneurons. The stratum lacunosum-moleculare contains the apical
dendrites of the pyramidal cells. In this layer, projections from the entorhinal
cortex, the nucleus reuniens and the thalamus terminate. The hippocampal
fissure or sulcus serves as border between dentate gyrus and the Ammon’s
horn. Layers of dentate gyrus : Closest to the hippocampal fissure is the stratum
moleculare. This layer mainly consists of dendritic trees of the granule cells.
The stratum granulosum or granule cell layer is comprised of the principal
neurons of the dentate gyrus. This layer is 6-8 cells thick, and together with
the stratum moleculare forms a V shaped structure. The polymorphic layer
(hilus) of the dentate gyrus consists of axons of granule cells (proximal part
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of mossy fibers), and of interneurons (accordingly to Martin, 2003; Insanti &
Amaral, 2004; Taupin, 2008; Amaral & Lavenex, 2006.)
Fig. 1.5: Anatomy of the regions used in this work. A. Anatomy of the hippocampus.
barrel field. S1Tr primary somatosensory cortex trunk region. Py- pyramidal cell layer, CA1,
CA2, CA3 regions of the pyramidal cell layer. Or- stratum oriens of hippocampus, Rad-
stratum radiatum, Lmol-stratum lacunosum-moleculare, Mol-stratum moleculare, DG-dentate
gyrus GrDG-granular layer of dentate gyrus, PoDG-polymorph layer of dentate gyrus (hilus,
modified from Paxinos & Franklin 2001 ). B. Anatomy of the cerebellum. GrLa-Granular
layer, MoLa-Molecular layer, PCLa-Purkinje cell layer. Bar=400 µm, for A and B (modified
from Paxinos & Franklin 2001). C. Barrel field in somatosensory cortex. Barrel components:
each barrel (B) is made up of a ring of high cell density, the side (stippling), which surrounds
a less cellular area, the hollow (H ). A wall (between hollow arrows) consists of the sides of
two adjoining barrels and the intervening septum (marked by black arrow). Roman numerals
indicate cortical layers. Bar=100 µm. (modified from Woolsey & der Loos, 1970).
1.4.1.2 Functions of the hippocampus
In rodents the hippocampus is most important for spatial memory and space
representation . The hippocampus contains so called place cells whose firing is
dependent on the mouse place in the space (O’Keefe & Nadel, 1978). Place
cells, together with head direction cells in the presubiculum (Taube et al.,
1990) and grid cells (Hafting et al., 2005) in the entorhinal cortex form the
system of spatial orientation in rodents. In human hippocampus, in addition
to the role in the spatial memory (people with bilateral hippocampal lesion can
recall old spatial memories but cannot achieve new memories; Teng & Squire,
1999; Rosenbaum et al., 2000), plays a role in explicit memory (memory with
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possibility of conscious recollection). Explicit memory is divided into episodic
(the ability to recollect previous experiences) and into semantic (the ability to
recollect general facts; Tulving, 1972). In patients with hippocampal lesions,
episodic memory is damaged more severe than the semantic memory. The
hippocampus is not involved in implicit memory (the type of memory that is
involved in the tasks which is not required the conscious recollection i.e the type
of memory which is used in professional activities, or for performing everyday
tasks, etc. Squire & Zola, 1997).
1.4.1.3 Pathology of the hippocampus
Diseases such as schizophrenia, epilepsy, Alzheimer’s disease and many others
cause pathological changes in the hippocampus. Most prevalent of them are
epilepsy and Alzheimer’s disease. Alzheimer’s disease has a higher prevalence
than epilepsy in developed countries because of high proportion of aged people.
For example in 2000, in USA 1.6% of population suffered from Alzheimer’s
disease (Hebert et al., 2003) and 0.9% of population suffered from epilepsy
(Begley et al., 2000), but in the whole world, epilepsy has a higher prevalence:
about 0.36% of the world population is suffering from Alzheimer’s disease
(Ferri et al., 2005), whereas about 0.4-1% of the world population is suffering
from epilepsy, and 40-70 new cases per 100000 people per year occur (Squire
& Zola, 1997; Sander, 2003). Most of all epilepsy cases are Temporal Lobe
Epilepsy (TLE) - a type of epilepsy that in 65 % of all cases is associated with
pathological changes in the hippocampus - Ammon’s Horn Sclerosis (AHS;
Engel, 1998). The main pathological changes in AHS are massive neuronal cell
loss and gliosis in the CA1 region, granule cell dispersion in the dentate gyrus,
and only minor cell loss in the CA3 region (Armstrong, 1993; Margerison &
Corsellis, 1966).
1.4.2 Primary somatosensory cortex
In rodents, the primary somatosensory cortex (S1) is a brain region, which
contains the body surface representation with a clear domination of the face
and whisker areas (Tracey, 2004). The S1 area in rodents is corresponding to
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the 3b area of the primate somatosensory cortex (Kaas, 2004). The primary
somatosensory cortex is a typical koniocortex (or granular cortex; Nieuwenhuys
et al., 2007) consist of six layers with layer IV rich in granular cells and poorly
distinguishable layers II and III (Wise & Jones, 1978). In addition to the
granular cells ,large body pyramidal cells were observed predominantly in the
layers III, V, VI (Simons & Woolsey, 1984). In layer IV of the part of S1
which represents the head, barrel structures are clearly visible (Fig.1.5 C). On
coronal sections, barrels are rectangular shaped and on tangential sections
elliptically shaped structures. Each barrel has a ring with high cell density
on the periphery named side. In the middle of the barrel, an area with lower
granule cells density is located named the hollow. Each barrel is separated
from adjacent cells by a nearly acellular structure -the septum (Woolsey & der
Loos, 1970). The number of barrels is corresponding to the number of whiskers
(vibrissae), and each barrel represents one whisker (Welker & Woolsey, 1974;
Woolsey et al., 1975).
1.4.3 Cerebellum
The cerebellum is part of the brain which plays a crucial role in motor coordi-
nation. The cerebellum is comprised of three main parts - cortex, white matter
and cerebellar nuclei (Martin, 2003) The cerebellar cortex (Fig.1.5 B) consists
of three layers. The superficial layer of cerebellar cortex is molecular layer
which contains processes of neurons and scattered cell bodies of small neurons.
The profound layer of cerebellar cortex is called granule cell layer. This layer
consist of densely packed small neurons. Between these two layers a single layer
is located - the Purkinje cell layer. In this layer, the cell bodies of big Purkinje
neurons are located (Mescher, 2009). In the same layer, Bergman glia cells are
located, which are a special type of cerebellar astrocytes (Grosche et al., 2002).
Even thought the main function of the cerebellum is motor coordination, it
also plays a role in implicit memory (Molinari et al., 1997; Doyon et al., 1997)
and in emotional control (reviewed by Schutter & van Honk, 2005).
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Chapter 2
Aim of this work
Despite of the growing knowledge about astrocytic connexins, their expression
pattern and function is not yet fully elucidated. The main goal of this study
was, by using novel transgenic tools, to clarify the expression pattern of the
astrocyic connexins Cx30 and Cx43 under normal conditions and in an epilepsy
model.
Specific aims of this work were:
1. Characterization of a novel Cx43 conditional knockout mouse, expressing
ECFP after Cre-mediated recombination,
2. Thorough analysis of the Cx30 and Cx43 expression patterns utilizing
reporter and fate mapping approaches.
3. Establishing an astrocytic fate mapping method to study the fate of
astrocytes in a mouse model of temporal lobe epilepsy .
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Chapter 3
Materials and Methods
3.1 Animals
Mice were kept under standard housing conditions (12 h/12 h dark–light cycle,
food and water ad libitum). All experiments were carried out in accordance
with local and state regulations for research with animals. All transgenic lines
were backcrossed at least 10 times to C57BL/6.
3.1.1 Cx30 KO animals
The Cx30 coding sequence of these mice has been replaced with a lacZ reporter
sequence under control of Cx30 gene regulatory elements (Teubner et al., 2003).
The lacZ-encoded βgalactosidase contains a nuclear localization signal.
3.1.2 Cx43fl(lacZ) and Cx43del animals
In Cx43fl(lacZ) animals, the Cx43 coding region is floxed. The floxed region is
followed by a lacZ gene which encodes βgalactosidase reporter with a nuclear
localization signal. As a result of Cx43 excision, the expression of βgalactosidase
is turned on under the control of the Cx43 gene regulation element (Theis et al.,
2001a). The Cx43del mouse is a result of breeding of Cx43fl animals with the
Deleter mouse (Schwenk et al., 1995). In Cx43del mice Cx43 is heterozygously
deleted in all cells of the body.
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3.1.3 Cx43 Cx30 double KO animals
Cx43 Cx30 double KO (DKO) animals are a result of the breeding of Cx30KO
animals with Cx43fl(LacZ) animals and hGFAPCre (Zhuo et al., 2001) animals.
DKO mice lack Cx30 in all cells of the body, and Cx43 in astrocytes. Homozy-
gous deletion of Cx43 in all cells of the body is lethal (Reaume et al., 1995;
Theis et al., 2001b).
3.1.4 R26R and R26R-EYFP reporters
R26R(Rosa) and R26R-EYFP(Rosy) are reporter mice for fate mapping and
monitoring of Cre expression. In R26R reporter mice, a splice acceptor sequence,
a neo expression cassette, flanked by loxP sites, a lacZ gene and a triple
polyadenylation (bpA) sequence were inserted in the ROSA26 locus (Soriano,
1999). R26R-EYFP contains as a reporter Enhanced Yellow Fluorescent Protein
(EYFP) instead of lacZ (Srinivas et al., 2001). As a result of breeding of these
reporter mice with mice expressing the Cre recombinase, the neo cassette is
excised and reporter gene expression is turned on in the cells expressing Cre
recombinase and in their descendants.
3.1.5 Cx30CreERT2:R26R-EYFP and Cx43CreERT:
R26R-EYFP
Cx43KI-CreERT mice express a tamoxifen-inducible Cre recombinase under
control of the Cx43 gene regulatory elements (Eckardt et al., 2004). In the
Cx30CreERT2 mice the construct, which contains CreERT that is expressed
under the control of the Cx30 regulatory elements, is inserted into large genomic
fragment of the Cx30 gene using the Bacterial Artificial Chromosome (BAC)
technology (Slezak et al., 2007). As a reporter R26R-EYFP was used.
3.1.6 Cx30CreERT2:Cx43fl(lacZ)
In this mouse, CreERT2 is expressed in the cells expressing Cx30. As a reporter
Cx43fl(lacZ) is used. In this mouse expression of βgalactosidase occurs in cells
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that express both Cx43 and Cx30.
3.1.7 NG2KI-EYFP:Cx43del mouse
This mouse was produced by breeding of NG2KI-EYFP mouse and Cx43del (see
3.1.2) mouse. NG2KI-EYFP mice express the EYFP under control of the NG2
gene-regulatory elements (Karram et al., 2008). In this mouse βgalactosidase
is expressed in the cells expressing Cx43 and EYFP is expressed in NG2 glia
(see 1.1.1.1 ). This double transgenic mouse is suitable for monitoring of Cx43
expression in NG2 glia.
3.1.8 Cx43fl(ECFP) and Cx43KI-ECFP mice
Cx43fl(ECFP) is a novel conditional KO mouse line expressing ECFP (Enhanced
Cyan Fluorescent Protein) instead for Cx43 after Cre mediated recombination
(Degen et. al unpublished results). The Cx43KI-ECFP mouse line was generated
by breeding Cx43fl(ECFP) mice, with PGK-Cre mice (Lallemand et al., 1998).
In Cx43KI-ECFP mouse one allele of Cx43 is deleted in all cells of the body,
and ECFP is expressed instead.
3.1.9 GFAPCreERT2:R26R
In GFAPCreERT2 mice the tamoxifen-inducible Cre is expressed in an astrocyte-
specific manner under control of a human GFAP promoter fragment (Hirrlinger
et al., 2006). R26R was used as a reporter. In GFAPCreERT:R26R mice,
expression of βgalactosidase in astrocytes is expected after tamoxifen injection.
3.1.10 GLASTCreERT:R26R
In the GLASTCreERT mice the construct, which contains CreERT that is
expressed under the control of the astrocyte-specific glutamate transporter
(GLAST) regulatory elements, is inserted into genome using BAC (Slezak et al.,
2007). As a reporter R26R was used. In GLASTCreERT:R26R mice expression
of βgalactosidase in GLAST-positive subpopulation of astrocytes is expected
after tamoxifen injection.
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3.2 Tamoxifen injection
Tamoxifen (Sigma, Munich, Germany) was dissolved in a 1:9 mixture of ethanol
and sunflower oil (Fluka, Ulm, Germany, Slezak et al. 2007). A stock solution
of 20 mg/ml was used. The solution was prepared daily. Mice were injected
intaperitoneally with 1 mg of this mixture twice a day, for 5 days.
3.2.1 Intrathecal injection
To avoid influence of the blood brain barrier on tamoxifen access to the brain,
animals were injected intrathecally (i.t.). Injections were performed according
to Wu et al. (2004). A catheter was made from 10.5 cm long polyethylene
tubes (PE10 Reiss Laborbedarf, Mainz-Mombach, Germany). The tubes were
warmed upon a hot plate until softening and were pressed and pulled to form
an elongated part and two buds as shown on the figure 3.1. A tungsten wire
with a diameter of 0.127 mm (MsWil, Wil, Switzerland) was inserted into the
tube as a guide. The catheter was inserted between vertebrae L4 and L5 of
the deeply anesthetized mouse, and left in place for one week. The correct
place of insertion was confirmed by 0.001 ml of Lidocaine (AstraZeneca, Wedel,
Germany) injection, which caused temporal paralysis of the hind paws, and
by a yellowish color of cerebrospinal fluid (which appears as a result of the
oil injection) during mouse dissection. Mice were injected with 0.001 ml of
ethanol/sunflower oil mixture twice a day.
Fig. 3.1: Construction of the catheter for intrathecal injection. (Wu et al., 2004).
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3.3 Chemicals and solutions
Chemicals and Reagents
Chemicals, Reagents Manufacturer
Ethanol Roth, Karlsruhe Germany
Methanol Roth, Karlsruhe Germany
Sterile Water B.Braun, Melsungen, Germany
Parafarmaldehide Roth, Karlsruhe Germany
Hoechst 33258 Invitrogen, Carlsbad, CA, USA
TritonX-100 Sigma, Munich, Germany
Ketamine (ketaminehydrochloride) Pharmanovo, Hannover, Germany
Cepetor® KH (medetomidinehydrochloride) CP Pharma, Burgdorf, Germany
Lidocaine AstraZeneca,Wedel,Germany
Sunflower oil Fluka, Ulm, Germany
Tamoxifen Sigma, Munich, Germany
Ringer Solution Fresenius Kabi, Bad Homburg,
Germany
Antisedan (atipamezolhydrochlorid) Orion Pharma, Espor, Finland
Draq5 Biostatus, UK, Shepshed
Biocytin Sigma, Taufkirchen, Germany
Kainate Tocris Bioscience, Bristol, UK
Normal Goat Serum (NGS) Millipore, Schwalbach, Germany
Streptavidine-CY3 Dianova, Hamburg, Germany
Tissue-Tek Sakura,Zoeterwoude, NL
VectaShield mounting medium Vector Laboratories, Burlingame,
USA
PermaFluor mounting medium Thermo Fisher Scientific, Fremont
USA
Tab. 3.1: Chemicals
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Solutions
Solution type Content
Phosphate Buffered Saline
(PBS)
150 mM NaCl, 8.3 mM Na2HPO4, 1.7 mM
NaH2PO4
Fixation solution
(4% Paraformaldehyd (PFA))
4% PFA in PBS
Cryoprotection solutions 1 x PBS with 30 % (w/v) sucrose
Artificial Cerebrospinal
Fluid (ACSF)
126mM NaCl, 3mM KCl, 2mM MgSO4, 2mM
CaCl2, 10mM glucose, 1.25mM NaH2PO4,
26mM NaHCO3, pH 7.4 (equilibrated with
95% O2/5% CO2).
Laird buffer 100 mM Tris, 5 mM EDTA, 0.2% SDS, 200
mM NaCl, pH adjusted with HCl to 8.5
Tab. 3.2: Solutions
Equipment
Equipment Manufacturer
Cryostat Microm, Walldorf, Germany
Stereotactic frame TSE Systems GmbH, Bad Homburg, Ger-
many
Wide-field fluorescence micro-
scope
Axiophot, Zeiss, Oberkochem, German
Confocal microscope Leica TCS, Pulheim, Germany
Digital SPOT camera Diagnostic Instruments, Sterling Heights,
MI,USA
Microsyringe Hamilton, Bonaduz, Switzerland
PCR cycler Biorad, Mu¨nchen, Germany
Tab. 3.3: Equipment
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3.4 Anaesthesia
Mice were deeply anesthetized by i.p. injection of 2:3 Ketamine/Cepetor 3.3µl/g
body weight. After surgery, Ketamine was neutralized by application of 100µL
1:5 Antisedan/Ringer solution per mouse. Later on animals were placed under
an infra-red lamp to avoid hypothermia.
3.5 Immunohistochemistry
Mice were deeply anesthetized and were perfused transcardially with 30 ml
PBS followed by 20 ml 4% PFA. Brains were removed and stored overnight at
4% PFA, in 4˚C, then the brains were transfered to 30% sucrose solution in
PBS for 2-4 days. Subsequently brains were embedded in Tissue-Tek, frozen,
and cut on a cryostat. Free floating sections were incubated in blocking solution
including 10% NGS and 0.4% TritonX100 in PBS for two hours. Sections were
incubated with primary antibody dissolved in blocking solution overnight in
4˚C. Sections were washed in PBS and incubated with secondary antibodies for
two hours. As secondary antibodies, we used goat anti-rabbit, goat anti-mouse
or goat anti-chicken conjugated to Alexa fluor 488, Alexa fluor 568 or Alexa
fluor 647 (1:500 Invitrogen, Karlsruhe, Germany). Sections were washed and
incubated with Hoechst (1:100) or alternatively with Draq5 (1:1000) for nuclear
staining and washed in PBS again. Section were mounted on the glass slides
using mounting medium and covered by cover slip.
Antibodies and Reactives
Antigen Origin Dilution Manufacturer
GFP(FITC coupled) Goat 1:500 Abcam
GFP Chicken 1:500 Abcam
GFP Mouse 1:500 Invitrogen
S100β Rabbit 1:1000 Abcam
S100β Rabbit 1:500 Swant
Iba1 Rabbit 1:500 Wako
Glutamine synthetase Mouse 1:250 Millipore
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Antigen Origin Dilution Manufacturer
βgalactosidase Mouse 1:500 Abcam
βgalactosidase Chicken 1:500 Abcam
βgalactosidase Rabbit 1:500 Invitrogen
NeuN neuronal marker Mouse 1:100 Millipore
NG2 Rabbit 1:100 Chemicon
GFAP(CY3 coupled) Mouse 1:500 Sigma
GFAP Rabbit 1:500 Dako
BLBP Rabbit 1:250 abcam
Tab. 3.4: Antibodies
Images were taken with a Zeiss Axiophot equipped with fluorescence optics, a
digital SPOT camera and MetaView software (Universal Imaging, West Chester,
PA,USA). Alternatively, fluorescent images were obtained with confocal laser
scanning microscopy (Leica TCS, Pulheim, Germany). Images were analyzed
using ImageJ software (NIH, Bethesda, Maryland, USA). For cell counting
image stacks were used. The step between two focal planes was 1µm. The
size of the individual image in the stack (one visual field) was 0.56 mm2.To
quantify β-galactosidase and ECFP reporter expression, cells were counted
in the stratum radiatum of the CA1 region fitting to one visual field. To
measure the efficacy of hGFAP at the allelic level, cells were quantified in
strata radiatum, oriens, and lacunosum-moleculare in the CA1 region. For
quantification of Cx30 upregulation, cells were counted in the cortex (all layers),
the CA1 region (strata radiatum, oriens, lacunosum-moleculare) and the dentate
gyrus of the hippocampus (hilus and granule cell layer). For comparison of
Cx30 and Cx43 expression utilizing inducible R26R-EYFP expression, 200µm
X 200µm counting boxes were used.
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3.5.1 Measurement of the relative area occupied by the
signal
For measurement of the upregulation of GFAP and Iba1 in the hippocampus of
the animals in the TLE model (see 3.8), changes in the area of the hippocampus
occupied by the specific immunofluorescent signal were measured. The image of
the whole hippocampus was obtained and the size of the area occupied by the
immunofluorescent signal was measured. The area was measured using ImageJ,
after adjusting a threshold using the ImageJ threshold plugin. The part of the
hippocampus occupied by the immunofluorescent signal was measured using
the following formula:
area fraction = area occupied by immunofluorescent signal
area of the hippocampus
The increase in the level of the immunofluorescent signal is a quotient of area
fractions occupied by the immunofluorescent sygnal in the contralateral and
ipsilateral side to kainate injection.
3.5.2 Measurement of granule cell dispersion
To quantify granule cell dispersion (see 4.2), we measured the width of the
granule cell layer of the medial (upper) blade of the dentate gyrus 50µm from
the edge.
3.6 Measurement of dye coupling
The measurements of dye coupled cells were performed as described (Wallraff
et al., 2004; Theis et al., 2003). Mice were anesthetized by Isofluran, decapitated,
the brains were quickly removed and 200 µm-thick coronal slices were cut on a
vibratome (VT1000S, Leica, Nussloch, Germany). During cutting, brains were
submerged in ice-cold oxygenated solution containing (in mM): 150 NaCl, 5
KCl, 2 MgSO4, 1 Na-pyruvate, 10 glucose, 10 HEPES, pH 7.4. Then, slices were
transferred into ACSF. For electrophysiological analysis, a slice was placed into a
recording chamber and continuously perfused with carbogenated ACSF at room
temperature. Cells were visualized using an upright microscope (Eclipse FN-1,
CHAPTER 3. Materials and Methods 30
Nikon, Du¨sseldorf, Germany) with infrared differential interference contrast
optics. Whole-cell voltage-clamp recordings were obtained from cells located in
the stratum radiatum of the CA1 subfield. Patch pipettes (3-6 MW) were filled
with (in mM): 130 K-gluconate, 1 MgCl2, 3 Na2-ATP, 20 HEPES, and 10 EGTA,
pH 7.2. Currents were recorded using an EPC8 amplifier (HEKA Elektronik,
Lambrecht, Germany). Data were sampled at 30 kHz, filtered at 10-30 kHz,
and monitored with TIDA software (HEKA). For tracer coupling analysis,
N-biotinyl-L-lysine (biocytin; Sigma, Taufkirchen, Germany) was added to
the internal solution (0.5%), and cells were loaded during 20 min recording in
the voltage-clamp mode. Only one astrocyte was filled with biocytin in any
individual slice. Immediately after recordings, slices were fixed in 4% PFA in
100 mM PBS, pH 7.4, at 4˚C. The slices were then incubated for two hours
with blocking solution consisting of 2% NGS in 0.1 M PBS with 0.1% Triton
X-100. Then, streptavidin-Cy3 (Dianova; 1:100) was applied overnight. The
reaction was stopped by washing with PBS. The slices were co-stained with
anti-GFP and anti-βgal antibodies. Slices were embedded in mounting medium
(VectaShield, Vector Laboratories, Burlingame, USA) and images were taken
as described above.
3.7 Genotyping
Animals were genotyped at the age of 4 weeks. Tail tips were cut and incubated
in Laird lysis buffer containing 0.2mg/ml proteinase K at 55˚C overnight. The
tail lysates were precipitated in isopropanol, centrifuged for 10 min at 14000
rpm, the supernatant was discarded, the pellet washed in 70% ethanol and
centrifuged again. The supernatant was discarded and the pellet was dried
for two hours. Extracted DNA was dissolved in 50µl of double distilled water.
Extracted DNA was analyzed by PCR using the GoTaq PCR kit and primers
mentioned in table 3.5.
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Primers and PCR program
Detects Program Primer sequence from 5’ to 3’ Product size
Cre and CreERT 94°C -1´,
(94°C-1´, 60°C-1´, 72°C-1´) X 30,
72°C-10´
Intcre-UP-TTT GCC TGC ATT
ACC GGT CGA TGC
Intcre-REV-TCC ATG AGT
GAA CGA ACC TGG TCG
400bp
GFAP-Cre 94°C -min´,
(94°C-1´, 60°C-1´, 72°C-1´) X 30,
72°C-10´
GFAP-LZ1-ACT CCT TCA TAA
AGC CCT CG
Cre-LZ4-ATC ACT CGT TGC
ATC GAC CG
200bp
GLAST-Cre 95°C-2’,
(95°C-30”, 65°C-30”, 72°C-70”) X 35
72°C-5’
GLASTCreERT2f-AAA TGT
GGG TGC TTG GTC TC
GLASTCreERT2r-AGG CAA
ATT TT GGT GTA CGG
1150bp
Cx43wt and Cx43fl 94°C-4´,
(94°C-2´, 65°C-1´, 72°C-1´30”) X 25
72°C-10´
43del-foward-GGC ATA CAG
ACC CTT GGA CTC C
UMPR-TCA CCC CAA GCT
GAC TCA ACC G
Cx43fl:650bp
WT:500bp
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Detects Program Primer sequence from 5’ to 3’ Product size
Cx43KO(lacZ) 95°C-5´,
(94°C-30”, 62°C-45” 72°C-1´30”) X 40,
72°C-10´
43del-foward-GGC ATA CAG
ACC CTT GGA CTC C
43del-rev-TGC GGG CCT CTT
CGC TAT TAC G
670bp
Cx43CreERT 95°C-5´,
(94°C-30”, 62°C-45” 72°C-1´30”) X 40,
72°C-10´
43-del-foward-GGC ATA CAG
ACC CTT GGA CTC C
Cx30CreERT2r-CAG GTT CTT
GCG AAC CTC AT
500bp
Floxed Cx43/CFP,
Floxed Cx43/Lacz,
Cx43KO/CFP
95°C-5´,
(95°C-30“, 65°C-30”, 72°C-1’) X 30,
72°C-10’
in-kod-reg-Cx43-GCT TCC CCA
AGG CGC TCC AGT CAC CC
fw-loxP-GCAC TTG GTA GGT
AGA GCC TGT CAG GTC
DSP-CFP-AAG AAG TCG TGC
TGC TTC ATG TGG
WT:340bp
floxedCFP:395bp
floxed-
LacZ: 450bp
Cx43KO/CFP:
700bp
Cx30CreERT2 95°C-2’,
(95°C-30”, 65°C-30”, 72°C-70”) X 35
72°C-5
Cx30CreERT2f-ATC ATG GGC
ATT CCT TCT CA
Cx30CreERT2r-CAG GTT CTT
GCG AAC CTC AT
1050bp
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Detects Program Primer sequence from 5’ to 3’ Product size
R26R
and R26R-EYFP
94°C-1´,
(94°C-45“, 67°C-30”, 72°C-40”) X 35,
72°C-5´
Rosa-WT-Xba-sense-TTT TGG
AGG CAG GAA GCA CTT G
Rosa-WT-Xba asense-GAA GGA
GCG GGA GAA ATG GAT A SA-
1as-GAC ATC ATC AAG GAA
ACC CTG GAC
WT:650bp
R26R:290bp
R26R recombined 94°C-1’,(94°C-45”, 67°C-30”, 72°C-40”)
X 25,
72°C-10’
Sas-GGT TGA GGA CAA ACT
CTT CGC
PGKas-CTA CCC GCT TCC
ATT GCT CAG
YFPas-CTC GTT GGG GTC
TTT GCT CAG
Recombined
R26R:829bp
Non-recombined
R26R:440bp
Cx30KO and Cx30
WT
94°C-5´
(92°C-45”, 60°C-45”, 72°C-45”) X 35,
72°C-10´
Cx30wt5-GGT ACC TTC TAC
TAA TTA GCT TGG
Cx30wt3-AGG TGG TAC CCA
TTG TAG AGG AAG
Cx30lacZ3-AGC GAG TAA CAA
CCC GTC GGA TTC
WT:544bp
KO:460bp
Tab. 3.5: Primers and PCR programs
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3.8 Temporal lobe epilepsy model
Dr. P. Bedner and Dr. K. Hu¨ttmann, Institute for Cellular Neurosciences
established a new model for TLE. In this model kainate is injected into the
cortex above the hippocampus, avoiding mechanical damage to hippocampus.
It is a big advantage over the TLE model with intrahipocamapal injection
(Heinrich et al., 2006). The mice subjected to TLE model with intrahipocampal
injections do not show spontaneous generalized seizures, and in these mice
impossible to investigate morphological change in CA1 region due to mechanical
damage in this region. Animals were anaesthetised with a ketamine/cepetor
mixture and injected stereotactically into the right parietal cortex (coordinates
from bregma point: AP:-1.9 mm and ML:-1.5 mm, DV: 1.8 mm) with kainate
using a Hamilton microsyringe. Animals were placed under an automatic
video recording system. Electroencephalograms (EEGs) were recorded using a
telemetric recording system (Data Sciences International (DSI), Minneapolis,
USA)
Fig. 3.2: Intracortical kainate injection. A. Schema of injection of kainate in the parietal
cortex. Note the placement of the Hamilton syringe (modified from MBL, courtesy of Dr.
Bedner). B. Injection of the blue dye into the cortex to simulate the kainate injection. The
dye diffused from the cortex to the hippocampus.
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3.9 Statistical Analysis
For data analysis R (R Development Core Team, 2010) and SPSS (PASW
statistics version 18) were used. Data are presented as mean ±Standard Error
of the Mean (SEM ). Differences were considered significant at p<0.05. T-test,
Mann–Whitney U test, ANOVA, Kruskal-Wallis rank sum test were used as
appropriate.
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Chapter 4
Results
4.1 Characterization of novel conditional Cx43
KO mice
We characterized novel Cx43 conditional KO mice, expressing ECFP instead of
Cx43, in the mouse brain. The mice were generated by Dr. Joachim Degen in
the laboratory of Prof. Dr. Klaus Willecke
4.1.1 Comparison of Cx43del and Cx43KI-ECFP mice
We compared the expression of cytoplasmic ECFP in the hippocampus of
Cx43KI-ECFP mice with the well-characterized expression of nuclear β-galacto-
sidase in Cx43del mice previously described (Theis et al., 2003, 2001b). We
found that the immunolocalization of ECFP and β-galactosidase in the hip-
pocampus was essentially the same (Fig. 4.1, Tab. 4.1). We observed a
high degree of colocalization of the astrocytic marker GFAP with both of the
Cx43-driven reporters (Fig. 4.1): 96.9% of all β-galactosidase positive cells
and 96.1% of all ECFP-positive cells expressed GFAP. By contrast, neither
β-galactosidase nor ECFP colocalized with the markers NeuN (Fig. 4.1 A3,
B3), NG2 (Fig. 4.1 A4, B4), or Iba1 (Fig. 4.1 A5, B5). For total numbers of
cells and animals counted, see Tab. 4.1.
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Fig. 4.1: Comparison of Cx43del and Cx43KI-ECFP mice. Double staining for ECFP
(A1-A5) or β-galactosidase (B1-B5) and the cell-type-specific markers GFAP (A1, B1),
S100β(A2, B2), NeuN (A3, B3), NG2 (A4, B4), and Iba1 (A5, B5) in the stratum radiatum
of the hippocampal CA1 region from Cx43KI-ECFP mice (A) and Cx43del mice (B). The
β-galactosidase contains an engineered nuclear localization signal, whereas the ECFP fills the
cell body and the fine astrocytic processes. Bar: 25 µm.
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Comparison of Cx43KI-ECFP and Cx43del mice
Cell Type
Marker
ECFP/Marker
Colocalization
Marker
only
ECFP
only
βgal/Marker
Colocalization
Marker
only
βgal only
NeuN 0/0%(6) 1953 711 0/0%(6) 1930 602
GFAP 1200/97.3%(12) 9 33 1194/96.7%(12) 37 40
S100β 1364/99%(12) 58 14 1241/99.1%(12) 79 11
NG2 0/0%(6) 186 667 0/0%(6) 152 486
Iba1 0/0%(6) 263 587 0/0%(6) 281 652
Tab. 4.1: Comparison of Cx43KI-ECFP and Cx43del mice. Number of counted cells followed
by percentage value of colocalization with the respective marker. Number of sections counted
in parentheses. 3 animals were screened per marker.
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4.1.2 Mutual exclusion of NG2 and Cx43 expression
shown with Cx43del/NG2KI-EYFP mouse.
To confirm the fact that NG2 cells do not express Cx43, we used Cx43del/NG2KI-
EYFP mice, expressing β-galactosidase in Cx43 positive cells and EYFP in
NG2 positive cells. No colocalization of these two signals was observed (225
EYFP and 1253 β-galactosidase positive cells from 3 different animals were
quantified). Thus, Cx43 is not expressed in NG2 cells.
Fig. 4.2: Mutual exclusion of NG2 and Cx43 expression shown with Cx43del/NG2KI-EYFP
mouse. B shows detailed images of the box in A. EYFP(green) is expressed in NG2 cells,
β-galactosidase (red) is expressed in Cx43 positive cells. No colocalization of β-galactosidase
and EYFP was observed. Scale bar 100µm.
4.1.3 Distinguishing Cx43 and Cx30 expression
The identical pattern of β-galactosidase and ECFP reporter expression al-
lowed us to use ECFP as a second reporter in new DKO mice (Cx30lacZ/lacZ;
Cx43fl[ECFP]/fl[ECFP]:hGFAP-Cre mice) which lacked both Cx30 (reporter:
lacZ) and Cx43 (reporter: ECFP). We analyzed double-deficient mice expressing
lacZ instead of Cx30 and ECFP after hGFAP-Cre-mediated ablation of Cx43.
We compared immunohistochemical stainings with those from conventional
DKO mice in which both Cx30 and Cx43 expression are represented by lacZ
expression. In the latter, β-galactosidase immunoreactivity of individual cells
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in Cx30lacZ/lacZ;Cx43fl[lacZ]/fl[lacZ]:hGFAP-Cre mice could indicate replace-
ment of i) Cx30, ii) Cx43 or iii) replacement of both genes. This precluded
the unambiguous allocation of reporter expression to a specific connexin gene
(Fig. 4.3A). By contrast, in Cx30+/lacZ;Cx43fl[ECFP]/+:hGFAP-Cre mice,
Cx30-driven lacZ expression (indicating lack of Cx30) and Cx43 driven ECFP
expression (indicating loss of Cx43) could be easily differentiated (Fig. 4.3B).
Fig. 4.3: Dual reporter-gene approach to distinguish Cx30 and Cx43 expression. A: Cere-
bellum of a Cx30lacZ/lacZ;Cx43fl[lacZ]/fl[lacZ]:hGFAP-Cre mouse. As β-galactosidase
(β-galactosidase) expression (red) indicates both Cx30- and Cx43-deletion, we cannot distin-
guish their respective distribution. Leptomeningeal cells, cells in the Purkinje and granular
cell layers were stained, consistent with expression of Cx30 and/or Cx43 in leptomeninges,
Bergmann glia and astrocytes (Theis et al., 2003). B: Double staining of distinct reporters
for Cx43 (ECFP, green) and Cx30 (β-galctosidase, red) in the cerebellum of a Cx30+/lacZ;
Cx43fl[ECFP]/+:hGFAP-Cre mouse. After Cre-mediated deletion of Cx43, ECFP is expressed
instead of Cx43. Cx30 is preferentially expressed in leptomeningeal cells and moderately ex-
pressed in some astrocytes of the granular cell layer, whereas Cx43 predominates in Bergmann
glia but is also expressed in some astrocytes of the granule cell layer. Some colocalization of
Cx30 and Cx43 is observed in yellow. Scale bar: 100µ for A-B.
4.1.4 Compensatory upregulation of Cx30 after Cx43
deletion
Immunoblot analyses suggested upregulation of Cx30 upon deletion of Cx43
(Theis et al., 2003, Nakase et al., 2004). We tested whether Cx30 is upregulated
in the hippocampus after ablation of Cx43. We did so, in situ, with double
immunofluorescence stainings for β-galactosidase (due to Cx30 replacement),
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and for ECFP (indicating Cx43 replacement), in Cx30lacZ/lacZ;Cx43fl[ECFP]/
fl[ECFP]:hGFAP-Cre mice. We found both in hippocampus and cortex a
strong upregulation of β-galactosidase immunoreactivity compared to Cre-
negative control mice (Fig. 4.4 A-D). The upregulation was pronounced in
the vicinity of the CA1 pyramidal cell layer in the strata radiatum and oriens
of the hippocampus (Fig. 4.4 A, C). It occurred throughout the cortex but
was less pronounced in layer I, which lacks pyramidal cell somata (Fig. 4.4
E, F). Such restriction of Cx30 upregulation to the vicinity of neuronal cell
bodies has also been observed in primary astrocytes co-cultured with neurons
(Koulakoff et al., 2008). We quantified the density of cells which express Cx30
in different brain areas (2 animals/genotype; 6 sections/animal; differences
between genotypes were significant (p <0.05), Fig 4.4): The Cx30-driven β-
galactosidase signal in the hippocampal CA1 region showed an 8-fold increase
(from 32.4 ±5.5 cells/mm2 in Cx30lacZ/lacZ;Cx43fl[ECFP]/fl[ECFP] mice
to 273.1 ±17.7 cells/mm2 in Cx30lacZ/lacZ;Cx43fl[ECFP]/fl[ECFP]:hGFAP-
Cre mice). In the hilus of the dentate gyrus, the number increased 22-fold
(from 13.2 ±2 to 294.4 ±14 cells/mm2). In the cortex, we observed a 2.2-fold
increase (from 261.5 ±14.1 to 570.7 ±15.2 cells/mm2). A similar increase
was observed in heterozygous Cx30+/lacZ mice: we found an increase of β-
galactosidase positive cell numbers from Cx30+/lacZ;Cx43fl[ECFP]/fl[ECFP]
mice to Cx30+/lacZ;Cx43fl[ECFP]/fl[ECFP]:hGFAP-Cre mice which was 7.6-
fold in the CA1 region (10.6±1.6mm2 to 80±10.2mm2), 14.1 fold in the hilus
(8.1±1.8mm2 to 113.4±12.9mm2), and 1.4-fold in cortex (311.5±32.9mm2 to
443.8±19.9mm2, 2 animals/genotype; 6 sections/animal; differences between
genotypes were significant). We conclude that hippocampal and cortical Cx30
gene activity is upregulated upon ablation of Cx43.
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Fig. 4.4: Compensatory upregulation of Cx30 after Cx43 deletion.A-F: Compensatory
upregulation of Cx30 after deletion of Cx43, monitored by the reporter-gene approach.
Cx30lacZ/lacZ;Cx43fl[ECFP]/fl[ECFP] mice (A, B, E) and Cx30lacZ/lacZ;Cx43fl[ECFP]/
fl[ECFP]:hGFAP-Cre mice (C, D, F), the latter expressing ECFP instead of Cx43. A-D:
Hippocampal CA1 region. A, C: Beta-galactosidase expression after Cx30 deletion (red); B,
D: Triple staining for Hoechst (blue), β-galactosidase (red) and ECFP (green). E, F: Cortex:
Beta-galactosidase (red), Hoechst (blue). Loss of Cx43 led to CFP immunoreactivity (D) and
to upregulation of Cx30-driven β -galactosidase expression (C, D, F). Bars: 100 µm for A-D
(bar in D), and 100 µm for E-F (bar in E).
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Fig. 4.5: Quantification of compensatory upregulation of Cx30 after Cx43 dele-
tion. A. The Cx30-driven β-galactosidase signal in the hippocampal CA1 in-
creased 8-fold in Cx30lacZ /lacZ;Cx43fl[ECFP]/fl[ECFP]:hGFAP-Cre compared to
Cx30lacZ/lacZ;Cx43fl[ECFP]/fl[ECFP] mice. In the hilus of the dentate gyrus, the number
increased 22-fold. In the cortex, we observed a 2.2-fold increase. B. A similar increase
was observed in heterozygous Cx30+/lacZ mice. In the CA1 region we observed 7.6 fold
upregulation, in the hilus an 14.1 fold upregulation, in cortex an 1.4 upregulation (2 ani-
mals/genotype; 6 sections/animal;) Cx30+/lacZ;Cx43fl[ECFP]/fl[ECFP]:hGFAP-Cre mice
compared to Cx30+/lacZ;Cx43fl[ECFP] /fl[ECFP] mice .
4.1.5 A dual reporter-gene approach to quantify the ef-
ficacy of Cre-mediated deletion.
Cre-mediated replacement of Cx43 by lacZ or by ECFP creates a dominant
signal. The reporter protein is expressed both after recombination of two floxed
alleles and after deletion of only a single allele; this cannot be distinguished. In
order to assess to which extent hGFAP-Cre deletes both floxed alleles, we raised
mice with different reporter-genes (lacZ and ECFP, respectively) on the two
floxed alleles of Cx43 (Cx43fl[ECFP]/fl[lacZ]:hGFAP-Cre mice). We measured
the content of β-galactosidase and ECFP coexpression in the hippocampal CA1
region (Fig. 4.6). We found that 90.9 ±4.3% of cells were double positive, while
4.1 ±3.2% expressed β-galactosidase only, and 5 ±2.8% of the cells expressed
ECFP only (3 animals; 4 sections/animal; 1135 cells counted). Thus in the
vast majority of cells, hGFAP-Cre deletes both alleles.
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Fig. 4.6: Efficacy of Cre-mediated deletion. A-C: Efficacy of Cre-mediated recombination at
the allelic level. Hippocampal section of a Cx43fl[ECFP]/ fl[lacZ]:hGFAP-Cre mouse, counter-
stained with Hoechst. GFP-antibody monitors Cre-mediated activation of ECFP reporter
from one floxed allele, and β-galactosidase antibody monitors activation of lacZ reporter
from the second floxed allele. Overlay of the three channels (A) demonstrates abundant
colocalization of both reporters. B,C - Blow-ups: Arrows indicate few cells expressing
β-galactosidase (B) or ECFP (C) only. Bar in A: 200 µm. Bar in C: 25 µm for B,C.
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4.1.6 Biocytin injection of ECFP positive cells in Cx43KI-
ECFP mice
Fig. 4.7: Biocytin injection of the ECFP
positive cells. ECFP positive cells were
injected in hippocampus cortex and tha-
lamus of Cx43KI-ECFP mouse. We com-
pared the percentage of Cx43-driven ECFP
positive cells among the biocytin-coupled
cells and found that it was significantly
different across brain regions.
Following electrophysiological investi-
gation of current pattern with whole
cell patch clamp (performed by Dr.
Peter Bedner, Dr. Kerstin Hu¨ttman
and Simon Ho¨ft), ECFP positive cells
were filled with biocytin in the hip-
pocampus (CA1 region, 18 cells),
the somatosensory cortex (7 cells),
and the thalamus (ventral postero-
lateral thalamic nucleus -VPL, ven-
tral posteromedial thalamic nucleus-
VPM, 10 cells). In the hippocampus
97%±0.6%, in the cortex 77%±1.8%
and in the thalamus 44%±4.6% of
the biocytin positive cells were ECFP
positive (the difference between pro-
portions of biocytin positive cells in
different regions were statistically sig-
nificant). This indicates astrocytic heterogeneity of connexin expression across
brain areas.
4.2 Cx43 Cx30 double KO mice in a TLE model
To study the role of glial connexins in epilepsy, Cx43/Cx30 double KO mice
(DKO) were subjected to our TLE model. As a control, litter mates lacking
hGFAP-Cre and therefore expressing Cx43 were used. Animals were analysed
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3 months after kainate injection. Three animals for each genotype were tested
(four sections per animal).
The control animals showed loss of neurons in the pyramidal cell layer
of the CA1 subregion in the hippocampus (neuronal loss was observed with
both NeuN staining and with Hoechst staining), while the CA3 region looked
largely intact (Fig. 4.8 A). Granule cell dispersion (GCD; Houser, 1990) was
measured by the width of the granule cell layer. On the ipsilateral (injected)
side, the granule cell layer was 3.57±0.12 times wider compared to the con-
tralateral (noninjected) side. Granule cells of the dentate gyrus lost their NeuN
immunoreactivity, and were visible only by Hoechst nuclear staining (Fig. 4.8
C). On the ipsilateral (injected) side the area occupied by astrocytes (GFAP)
was increased 2.16±0.311 times in comparison to the contralateral side. The
area occupied by Iba1 (microglia marker) was increased 3.37±0.53 times at
the injected side. All these findings correspond to typical changes in Ammons
Horn sclerosis (Armstrong, 1993).
DKO animals showed pyramidal cell loss in the CA1 region. Granule cells
still had NeuN immunoreactivity (Fig. 4.8 B,D ). The GCD was significantly
less pronounced compared to control animals. The granule cell layer on the
ipsilateral side was only 1.33±0.13 times wider compared to the ipsilateral side.
The increase of the area occupied by Iba1 immunoreactivity was 1.87±0.22,
significantly lower compared to control mice. The increase in GFAP expression
was 1.8±0.13, which was not different from the control mice.
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Fig. 4.8: Morphological changes of DKO and control mice in the TLE model. A-B: NeuN
(red) and Hoechst (blue) stainings 6 weeks after kainate injection in control (A) and DKO
(B) mice.GCD was less pronounced in DKO mice compared to controls. Bar in B is 250µm
for A-B. C,D. Blow-up of granule cell layer of dentate gyrus of control and DKO animals
respectively. C. in granule cell layer of control animals observed loss of immunoreactivity to
NeuN (C), no such reduction in immunoreactivity observed in DKO animal (D) Bar in D is
50µm for C-D. E. GCD. The relative GCD was significantly higher in the control animals.
F. No significant difference in increase of GFAP levels. G. The increase of Iba1 level was
significantly higher in control animal.
CHAPTER 4. Results 48
4.3 Quality control of Cx30/Cx43 double KO
mice.
During experiments on Cx43fl(lacZ)Cx30-/-: hGFAP-Cre (conditional DKO of
Cx30 and Cx43 in astrocytes expressing LacZ instead of Cx43 and Cx30), we
observed a reduction of function or no function of the hGFAP-Cre recombinase
(Pseudo DKO). The extent of reporter positive astrocytes in the dentate
gyrus was determined by double immunofluorescence analysis for GFAP and β-
galactosidase: Cx30-/-;Cx43fl/fl mice were essentially devoid of β-galactosidase
immunoreactivity in the hilar region (Fig. 4.9A). By contrast, DKO mice
with efficient deletion showed numerous reporter gene expressing astrocytes
(Fig.4.9 B). In pseudo DKO mice (Fig. 4.9C), the number of β-galactosidase
positive cells was strongly decreased. In regions other than the hippocampus,
the reduction of β-galactosidase expression due to Cx43 deletion could be
masked by β-galactosidase expression due to Cx30 deletion. We correlated Cre
expression with Cx43 ablation in situ by immunofluorescence detection of Cre
recombinase in cerebellar cryosections. In DKO mice, Cre immunoreactivity
within the Purkinje cell layer showed a distribution typical of the Bergmann
glia nuclei (Fig. 4.9 E), whereas Cx30-/-;Cx43fl/fl control mice merely showed
nonspecific background staining in blood vessels (Fig. 4.9 D) essentially identical
to full pseudo-DKO mice (Fig. 4.9 F).
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Fig. 4.9: Expression of β-galactosidase and Cre recombinase in DKO and pseudo-DKO
animals.(A-C) Double immunofluorescence staining for GFAP and β-galactosidase in the
hilar region of the dentate gyrus. (A) A Cx30-/-;Cx43fl/fl animal shows absence of β-
galactosidase expression in the hippocampus consistent with virtual absence of Cx30 driven β-
galactosidase expression in the hippocampus of Cx30 KO animals. (B) DKO mouse expressing
β-galactosidase at a high level (C) Pseudo DKO animals shows only scattered expression of
β-galactosidase. Scale bar: 50µm. D–F Immunohistochemical evaluation of Cre expression
in DKO mice versus Cx30-/-;Cx43fl/fl controls in the cerebellum. Immunofluorescence
analysis for Cre expression (red) from DKO mice, pseudo DKOs, and control mice. Hoechst
counterstain (blue) was used to demarcate the border between molecular layer and granular
layer (the cell density is higher in granular layer). (D) Cx30-/-;Cx43fl/fl mice are negative
for Cre antibody staining (red). Some vessel-associated background staining is observed. (E)
DKO mice with efficient Cx43 ablation show immunoreactivity for Cre in the Bergmann
glia nuclei. (F) Full pseudo DKO mice lack immunoreactivity in Bergmann glia and are
indistinguishable from Cre negative control mice. Bar in F is 50 µm for D-F.
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4.4 Comparison of Cx30 expression monitored
by different constitutively expressed and
inducible reporter genes.
4.4.1 Cx30KO mouse: reporter gene experiments
The Cx30lacZ/lacZ mouse expresses an NLS-lacZ gene (a lacZ gene containing
a nuclear localization signal) instead of Cx30 (Teubner et al., 2003). Therefore,
LacZ expression represented transcriptional activity of the Cx30 gene. In the
cerebellum β-galactosidase immunoreactivity was frequently observed in the
granular cell layer and in leptomeninges (Fig.4.10 A1). No β-galactosidase signal
was detected in the molecular layer. In the cerebral cortex, β-galactosidase pos-
itive cells were found mostly in medial cortical layers (Fig.4.10 B1). Expression
was prominent in leptomeningeal cells (Fig.4.10 B1). Very low immunoreactiv-
ity was observed for β-galactosidase in the hippocampus (Fig. 4.10 C1). We
quantified the number of lacZ expressing cells in cerebral cortex and hippocam-
pus: 420.2 ±10.9 cells/mm2 showed lacZ expression in the cerebral cortex,
while 52.5 ±4.9 cells/mm2 expressed the reporter in the hippocampal CA1
region of Cx30lacZ/lacZ mice (3 animals, 6 sections per animal). In the same
sections, widespread β-galactosidase immunoreactivity was observed in the
thalamus (not shown). Since considerable Cx30 expression in hippocampal
astrocytes has been reported previously (Nagy et al., 1999; Theis et al., 2005),
but we observed very low hippocampal β-galactosidase signal in the hippocam-
pus of Cx30lacZ/lacZ mice (Fig 4.10C), we deemed further investigation of
hippocampal Cx30 expression necessary (see 4.4.2).
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Fig. 4.10: Cx30 expression visualized by a reporter gene approach. Immunofluorescent
staining for β-galactosidase of sections from a Cx30lacZ/lacZ mouse. The β-galactosidase
staining (green) was observed in nuclei (stained with Hoechst dye, blue) in the cerebellum
(A1) and the cerebral cortex (B1), but was very infrequent in the hippocampus (C1). A2,
B2, C2: Insets from corresponding merged pictures, showing the β-galactosidase signal. A3,
B3, C3: Hoechst nuclear stain. Arrows indicate colocalization of β-galactosidase and nuclear
stain. GCL: Granule cell layer. Mol: Molecular layer. L: Leptomeningeal cell layer. I-V:
Layers of the cerebral cortex. LMol: Stratum lacunosum moleculare. Rad: Stratum radiatum.
Py: Pyramidal cell layer. Or: Stratum oriens. Scale Bar: 100µm.
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4.4.2 Reporter activation mediated by Cx30CreERT2
transgenic mice in astrocytes
Utilizing a reporter gene, we scored Cx30CreERT2-mediated activation of a
lacZ reporter gene driven by gene regulatory elements of the Cx43 gene (Theis
et al., 2001b) in Cx30CreERT2:Cx43fl/+ mice. In this case lacZ expression
indicated that the Cx30 gene and the Cx43 gene were active in the same cells.
In double staining for S100β and β-galactosidase indicating Cx30CreERT2-
driven recombination in Cx43 expressing astroglial cells (Fig. 4.11), we found
similar numbers of double positive cells in the hippocampal CA1 region (25.7
±4.4 cells/mm2) and cerebral cortex (27.0±3.5 cells/mm2) of Cx30CreERT2:
Cx43fl/+ mice (3 animals, 6 sections per animal). This served as evidence that
Cx30 expression is similarly abundant in cerebral cortex and hippocampus,
other than indicated by the Cx30 driven lacZ reporter embedded in the Cx30
KO allele.
Fig. 4.11: A cre-based reporter approach indicates similar co-expression frequency of Cx30
with Cx43 in hippocampus and cortex. Hippocampus (A–D) and cerebral cortex (E–H) of
Cx30CreERT2:Cx43fl/+ mice were stained with antibodies directed to S100β (A, E) and
β-galactosidase (B,F), and Hoechst nuclear stain (C,G). Overlay (D,H) shows colocalization
(arrows) of S100β (red), β-galactosidase (green) and nuclear stain (blue). Bar=50µm.
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4.4.3 Expression levels of Cx43 and Cx30 in the hip-
pocampus, primary somatosensory cortex, cere-
bellum, and thalamus assessed by R26R-EYFP
reporter mice.
To compare the expression of Cx43 with Cx30 in hippocampus, cortex, thala-
mus, and cerebellum the co-expression of S100β and EYFP was investigated in
Cx43CreERT:R26R-EYFP and in Cx30CreERT2:R26R-EYFP mice (3 animals,
6 sections for each genotype). This not only allowed us to compare expression
of Cx43 with Cx30 in varios brain regions, but also to compare the efficacy
of the inducible Cre transgene in different areas. In the CA1 region of the
hippocampus, we calculated the proportion of EYFP positive astrocytes coex-
pressing S100β (see Fig. 4.12 A1-A4). In Cx43CreERT:R26R-EYFP mice, 57.8
±3.6% of S100β positive cells colocalized with EYFP and in the hippocampus
of Cx30CreERT2:R26R-EYFP mice, 43.6±1.7% of S100β positive cells colo-
calized with EYFP (Fig 4.12 B1-B4). This difference in the proportions of
S100β/EYFP double positive cells was significant.
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Fig. 4.12: Expression levels of Cx30 and Cx43 in the hippocampus assessed by R26R-
EYFP reporter mice. A, B: Colocalization of S100β and EYFP. A: Hippocampus of a
Cx43CreERT:R26R-EYFP mouse. B: Hippocampus of a Cx30CreERT2:R26R-EYFP mouse.
A1, B1: S100β. A2, B2: EYFP. A3,B3: Hoechst. A4,B4: overlay of S100β (red), EYFP-
(green) and nuclear stain (blue). Cells in which S100β and EYFP colocalized are yellow.
Bar=100µm.
In the primary somatosensory cortex, we analyzed the so-called barrel field and
the regions receiving input from shoulder, hind limb and trunk regions (Fig.
4.13 A,B). In of Cx43CreERT:R26R-EYFP mice, 38±3% of S100β positive cells
coexpressed EYFP, while a higher percentage, namely 58±2% of S100β positive
cells coexpressed EYFP in Cx30CreERT2:R26R-EYFP mice. This difference
in the proportions of S100β/EYFP double positive cells was significant. In
non-barrel regions of the primary somatosensory cortex of Cx43CreERT:R26R-
EYFP mice, 52±4% of S100β positive cells colocalized with EYFP, while in
Cx30CreERT2:R26R-EYFP mice, 50±3% of S100β positive cells colocalized
with EYFP. This difference in the proportions of S100β/EYFP double positive
cells was not significant. The proportions of S100β/EYFP double positive cells
in barrel compared to non-barrel regions in Cx43CreERT:R26R-EYFP mice
was significantly different , while no significant differences were observed in
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Cx30CreERT2:R26R-EYFP mice.
We analyzed EYFP expression in the barrels and in the septa between
the barrels in the primary somatosensory cortex. We observed a similar
level of expression in the barrels and in the septa between the barrels. In
Cx43CreERT:R26R-EYFP mice, in the barrels, 39.3±3.7% and in the septa
33±4% of S100β positive cells were also EYFP positive. In Cx30CreERT2:R26R-
EYFP mice, in the barrels, 54.5±4% of S100β positive cells were also EYFP
positive, while in the septa the number of S100β/EYFP positive cells was very
similar- 53.3±6.5% These differences were not statistically significant for both
mice type.
In the thalamus, EYFP expression in the ventral posterolateral thalamic
nucleus (VPL) and the ventral posteromedial thalamic nucleus (VPM) was
analyzed (Fig.4.13 C,D). In Cx43CreERT:R26R-EYFP mice, 40±3% of S100β
positive cells colocalized with EYFP and in Cx30CreERT2:R26R-EYFP mice,
43±2% of S100β positive cells colocalized with EYFP. This difference was not
statistically significant.
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Fig. 4.13: Expression levels of Cx43 and Cx30 in the primary somatosensory cortex and
thalamus assessed by R26R-EYFP reporter mice. A-D: Colocalization of S100β and EYFP A:
Cortex of Cx43CreERT:R26R-EYFP mouse. B: Cortex of Cx30CreERT2:R26R-EYFP mouse
C: Thalamus of Cx43CreERT:R26R-EYFP mouse. D: Thalamus of Cx30CreERT2:R26R-
EYFP mouse. A4,B4,C4,E4- overlay of S100β (red), EYFP- (green) and nuclear stain (blue).
Cells in which S100β and EYFP colocalized are yellow. Bar=50µm.
S100β EYFP Hoechst S100β/EYFP/Hoechst
C
x
43
C
re
E
R
T
C
x
30
C
re
E
R
T
2
C
x
43
C
re
E
R
T
C
x
30
C
re
E
R
T
2
C
or
te
x
T
ha
la
m
u
s
CHAPTER 4. Results 57
In the cerebellum, the proportion of the EYFP positive Bergmann glia
expressing S100β (see Fig. 4.14) was calculated. In the Cx43CreERT:R26R-
EYFP mice, 64.4±2.8 % of S100β positive cells expressed EYFP and in
Cx30CreERT2:R26R-EYFP mice, 64.3±2.3% of S100β positive cells colocalized.
This difference was not statistically significant.
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Fig. 4.14: Expression levels of Cx30 and Cx43 in cerebellum assessed by R26R-EYFP
reporter mice. A: Cerebellum of a Cx43CreERT:R26R-EYFP mouse. C: Cerebellum of a
Cx30CreERT2:R26R-EYFP mouse. B,D show detailed images of the boxes in A,C. S100β:
red, EYFP: green, Hoechst nuclear stain: blue. Cells in which S100β and EYFP colocalized
are yellow. Bar=100µm.
S100β/EYFP/Hoechst
C
x
43
C
re
E
R
T
:R
26
R
-E
Y
F
P
C
x
30
C
re
E
R
T
2:
R
26
R
-E
Y
F
P
CHAPTER 4. Results 59
Figure 4.15 summarizes the results obtained using Cx43CreERT:R26R-EYFP
and Cx30CreERT2:R26R-EYFP transgenic mice: In the hippocampus
Cx43CreERT led to higher recombination efficacy, reproducing our previous
findings (Gosejacob et al., 2011). In the barrel cortex, Cx30CreERT2 has higher
recombination efficacy, while in non barrel regions of the cortex, in thalamus
and in cerebellum the efficacies of both inducible Cre lines were similar.
Fig. 4.15: Ratio of EYFP/ S100β double positive cells to all S100β positive cells in
hippocampus, somatosensory cortex (somatosensory cortex barrel field and non-barrel field),
thalamus and cerebellum of Cx43CreERT:R26R-EYFP and Cx30CreERT2:R26R-EYFP mice.
The proportion of double positive cells in the hippocampus of Cx43CreERT:R26R-EYFP
was significantly higher than in Cx30CreERT2:R26R-EYFP mice. In the barrel cortex, the
proportion of double positive cells was significantly higher in Cx30CreERT2:R26R-EYFP mice.
The proportion of the double positive cells in non barrel cortex, thalamus and cerebellum
was similar in both transgenic mice. The proportion of double positive cells in the non-barrel
cortex was significantly higher than in barrel cortex of Cx43CreERT:R26R-EYFP mice.
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4.5 Comparing the role of Cx43 and Cx30 pos-
itive stem cells in neurogenesis
In the adult brain exist two main neurogenic niches -SGZ and SVZ. We
compared the role of Cx30 and Cx43 in adult neurogenesis in the SGZ. For this
purpose we analyzed the number of neurons generated from Cx43 and Cx30
positive RG-like cells.
4.5.1 Number of the generated neurones
Cx43CreERT: R26R-EYFP and Cx30CreERT2:R26R-EYFP mice were stained
for NeuN and EYFP (3 animals per genotype, 6 sections each) (see Fig4.16).
Cells in SGZ, and in the granule cell layer of the dentate gyrus were scored
for double positive cells (3 animals per genotype, 6 sections each). In SGZ of
Cx43CreERT:R26R-EYFP mice, 9.4±1.6 % of EYFP positive cells were NeuN
positive (or 3.1±0.5 cells per section), and in the SGZ of Cx30CreERT2:R26R-
EYFP mice, 1.7±0.8% of EYFP positive cells were NeuN positive (or 0.5±0.2
cells per section). The difference in expression levels was statistically significant.
In the granule cell layer, these values were 8.7±3 % (or 1±0.3 cells per section)
and 0.95±1.7% (or 0.17±0.09 cells per section) respectively. The difference in
expression levels was statistically significant.
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Fig. 4.16: Double labelling for NeuN and EYFP R26R-EYFP reporter mice. A,B: Dentate
gyrus of Cx43CreERT:R26R-EYFP mouse stained for EYFP (green), NeuN (red) and Hoechst
(blue). C, D: Cx30CreERT2: R26R-EYFP mouse stained for EYFP (green), and NeuN (red)
and Hoechst (blue). Arrows point to double positive cells in the granule cell layer A,C, and in
the SGZ B,D. E: Proportion of NeuN/EYFP double positive cells of all EYFP positive cells in
the granule cell layer and SGZ of Cx43CreERT:R26R-EYFP and Cx30CreERT2:R26R-EYFP
mice. F: Absolute number of NeuN/EYFP double positive cells per section in the granule cell
layer (GCL) and SGZ of Cx43CreERT:R26R-EYFP mice and Cx30CreERT2:R26R-EYFP
mice. Bar=50µm.
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4.5.2 Number of Cx43 and Cx30 positive RG-like cells
To assess the number of Cx43 and Cx30 positive RG-like cells we used double
staining for the RG-like cells marker Brain Lipid Binding Protein (BLBP; Feng
et al., 1994) and EYFP in Cx43CreERT:R26R-EYFP and Cx30CreERT2:R26R-
EYFP mice (Fig. 4.17). In Cx43CreERT:R26R-EYFP mice 40.1±3.4% of BLBP
positive cells were also EYFP positive, vs. 10.7±1.2% in Cx30CreERT2:R26R-
EYFP mice. The difference was statistically significant.
Fig. 4.17: Double labelling for BLBP and EYFP in R26R-EYFP reporter mice recombined
by Cx43CreERT or Cx30CreERT2. A: The dentate gyrus of a Cx43CreERT:R26R-EYFP
mouse was stained for EYFP (green) BLBP (red) and Hoechst (blue). B: A Cx43CreERT:
R26R-EYFP mouse was stained for EYFP (green), BLBP (red) and Hoechst (blue). C:
Proportion of BLBP/YFP double positive cells of all BLBP positive cells in the SGZ of
Cx43CreERT:R26R-EYFP mice and Cx30CreERT2:R26R-EYFP mice. We analyzed 3
animals per genotype, 6 sections for each animal. Bar=50µm.
4.6 Fate mapping of astrocytes in TLE
In the hippocampus of TLE patients, astrocytes disappeared, and most of the
glial cells remaining in the hippocampus were NG2 positive cells (Hu¨ttmann
and Bedner, unpublished results). The aim of this project was to study the
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fate of astrocytes in a TLE model, to answer the question -if they just died or
acquired another phenotype.
4.6.1 Establishing a method for fate mapping of astro-
cyte in a model for temporal lobe epilepsy
Several transgenic mice with inducible Cre recombinase were tested for suitabil-
ity to the study the fate of astrocytes in the hippocampus in our TLE model.
We used GLASTCreERT mice with Cx43fl(LacZ) as a reporter, GFAPCreERT
mice with R26R as a reporter, and Cx43CreERT and Cx30CreERT2 mice
with R26R-EYFP as a reporter. By application to wild type mice the maxi-
mal non-letal dose of tamoxifen was determined, which was 1 mg i.p. twice
a day. Application of tamoxifen for 5 consecutive days to GFAPCreERT
mice, as well as intrathecal injection of tamoxifen did not cause any expres-
sion of reporter in the hippocampus (Fig. 4.18 A). Only weak expression of
β-galactosidase in the cerebellum was observed. Intraperitoneal injection of
tamoxifen into GLASTCreERT mice caused a very low level of recombina-
tion in the hippocampus (Fig. 4.18 B). However application of tamoxifen to
Cx43CreERTR26R-EYFP and Cx30CreERT2:R26R-EYFP mice resulted in
strong recombination in the CA1 region of the hippocampus (see section 4.4.3
and Fig. 4.12)
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Fig. 4.18: Induction of the Cre mediated recombination in two different mouse models
A. Using GFAPCreERT:R26R no β-galactosidase expression in hippocampus was observed.
B. Using GLASTCreERT:Cx43fl(LacZ) only low level of β-galactosidase expression in hip-
pocampus was observed. Or - stratum orience, Rad - stratum radiatum, Py and dotted line -
stratum pyramidale, Bar=100µm
4.6.2 Cx43CreERT:R26R-EYFP mice subjected to our
TLE model induced by intracortical injection of
kainate.
We chose to use Cx43CreERT:R26R-EYFP mice in our TLE model because
of the high recombination efficacy in the hippocampus (see 4.4.3 and Fig.
4.15). An important prerequisite to use of fate mapping approach is lack of
Cx43CreERT induced recombination in NG2 cells in the normal brain. We
tested this, and found that Cx43CreERT:R26R-EYFP animals after tamoxifen
induction do not show colocalization of the EYFP signal with the NG2 signal
in the CA1 region of the hippocampus (3 mice, 3 sections per mouse were
tested). Cx43CreERT:R26R-EYFP animals subjected to our TLE model of
intracortical kainate injection , showed GCD, pyramidal cell loss and reactive
gliosis 6 months after kainate injection (similar changes are observed in human
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TLE (Armstrong, 1993)). To evaluate the fate of astrocytes, we screened the
sections stained for EYFP and NG2 for double positive cells. No colocalization
of EYFP with the NG2 signal was observed (Fig.4.19A), and most of the
EYFP positive were also GFAP positive (Fig.4.19B). A small fraction of EYFP
positive cell was neither NG2 nor GFAP positive (Fig.4.19 C,D; 3 mice, 3
sections per mouse were tested). This indicated that astrocytes in TLE do not
transdifferentiate into NG2 cells. The finding of recombined, GFAP negative
cells indicates that astrocytes may acquire an atypical phenotype.
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Fig. 4.19: Cx43CreERT:R26R-EYFP mice subjected to a model of TLE induced by in-
tracortical injection of kainate. Staining of the CA1 region. A: EYFP (green), NG2 (red)
and Hoechst (blue). No colocalization of NG2 with EYFP was observed. B. EYFP (green),
GFAP (red) and Hoechst (blue). Most of EYFP positive cells are GFAP positive. C: Normal
morphology of the NG2 cells from the contralateral to kainate injection side. D,E: Some
EGFP positive cells showed no immunorectivity for GFAP or NG2. EYFP (green), GFAP
(red) and Hoechst (blue). Bar in A: 50 µm, for A,B. Bar in C:25 µm, Bar in E: 25 µm for
D,E.
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4.7 Quality control of Cx43CreERT:R26R-EYFP
We observed spontaneous (uninduced) recombination of Cx43CreERT:R26R-
EYFP by PCR analysis of tail tip DNA (not shown). These mice possessed
the R26R-EYFP recombined allele, without tamoxifen injection, as revealed by
PCR analysis. On immunofluorescent stainings from brain sections of these
mice, we observed a high number of neurons expressing EYFP (Fig. 4.20 A) and
a low number of EYFP expressing astrocytes (Fig. 4.20 C), in comparison to
the Cx43CreERT:R26R-EYFP animals with proper recombination induced by
tamoxifen injection. The frequency of the spontaneous recombination was 7.5%
(3 of 40 mice). No such phenomenon was observed in Cx30CreERT2:R26R-
EYFP (40 mice were analysed).
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Fig. 4.20: Spontaneous recombination in Cx43reERT:R26R-EYFP mice in the CA1 region
of the hippocampus. A, C: Sections from a mouse with spontaneous recombination (without
induction by tamoxifen). Note the high level of colocalization of NeuN with EYFP in the
pyramidal cell layer in A. B, D: Sections from a Cx43CreERT:R26R-EYFP mouse with proper
recombination induced by tamoxifen injection. A,B: NeuN-(red), EYFP-(green) and nuclear
stain Hoechst -(blue). C,D: S100β -(red) EYFP-(green) and nuclear stain Hoechst -(blue).
Bar=100µm.
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Chapter 5
Discussion
5.1 Characterization of a novel conditional KO
mouse
Gene inactivation reporters show loss of gene expression in each individual
mouse, but in double knockout mice which use identical reporters, it is impossi-
ble to differentiate loss of one or the other gene, or both of the genes. This is the
situation in Cx43/Cx30 DKO mice we and others already described (Wallraff
et al., 2006; Rouach et al., 2008) . With a novel conditional transgenic mouse
line recently generated by J. Degen, expressing the enhanced cyan fluorescent
protein (ECFP) instead of Cx43 after Cre-mediated recombination, we present a
new concept - a dual reporter approach - to differentiate loss of Cx30 expression
(lacZ) from loss of Cx43 expression (ECFP). In contrast to hGFAP/EGFP
mice with labeling of both astrocytes and GluR/NG2 cells (Matthias et al.,
2003), fluorescence in Cx43kiECFP mice is invariably confined to astrocytes.
Furthermore, we analyzed a new conditional KO construct for Cx43: In cells
with Cx43 gene-activity, ECFP was expressed after Cre-mediated Cx43 ab-
lation. By this approach with different reporter-genes, we could differentiate
Cx30 from Cx43 expression. It gives us a opportunity to study expression
of each connexin. Upon Cx43 ablation, Cx30 was upregulated, preferentially
in the vicinity of pyramidal cells, i.e. in stratum radiatum adjacent to the
hippocampal pyramidal cell layer and in stratum oriens, as well as in all layers
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of the cortex except for layer I. Both Cx43 and Cx30 constitute astrocytic gap
junctions and allow interastrocytic coupling in the hippocampus. This was
inferred from three observations: (1) Mice lacking Cx43 show residual interas-
trocytic coupling amounting to 50% of control conditions (Theis et al., 2003).
(2) DKO mice lacking both connexins exhibit complete loss of interastrocytic
tracer spread in the hippocampus (Rouach et al., 2008; Wallraff et al., 2006).
(3) Tracer spread in Cx30-deficient mice showed 22% decrease of interastro-
cytic coupling (Gosejacob et al., 2011). Thus, coupling of astrocytes in the
hippocampus predominantly depends on Cx43. Obviously, Cx43 and Cx30 do
not have a simple additive role in mediating gap junction communication. This
discrepancy could be explained by observed upregulation of the Cx30 in Cx43
KO mice. The exact mechanism by which Cx30 is upregulated upon loss of
Cx43 requires further investigation.
In a second approach, we used two different reporters of gene-inactivation at
the same genetic locus. We assessed the efficacy of Cre-mediated recombination
at the level of individual cells and individual alleles. In this way we can
estimate the efficacy of conditional KO, i.e. weather after recombination both
alleles of Cx43 are deleted, or one of them remains intact. Indeed, hGFAP-Cre
deleted both floxed Cx43 alleles in the majority of cells expressing Cx43 in the
hippocampus. Few cells lost only one allele and might have expressed residual
Cx43 protein. Such an assessment of complete deletion within a cell is even
more important for inducible Cre-recombinase transgenes, which are expected
to be less active compared to their constitutive versions (Zhuo et al., 2001;
Hirrlinger et al., 2006). In conclusion, we here present conceptual advances of
gene inactivation reporters – dual reporter approaches – which allow identifying
compensatory regulation of genes and which allow quantifying the efficacy of
Cre-mediated gene inactivation - both with single cell resolution in situ.
5.2 Evaluation of Cx30 expression in the brain
Contradictory findings about Cx30 expression assessed by a reporter gene
in Cx30lacZ/lacZ mice (Requardt et al., 2009; Theis et al., 2005) and from
previous immunohistochemical studies (Nagy et al., 1999) prompted us to
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reinvestigate hippocampal Cx30 expression. Expression of Cx30 in hippocampal
astrocytes has been reported previously (Nagy et al., 1999; Rouach et al.,
2008). Immunoblotting and immunoflourescence experiments indicated similar
abundance of Cx30 in cerebral cortex and hippocampus (Gosejacob et al.,
2011). In all areas gap junction plaques composed of Cx30 were found at blood
vessels (Rouach et al., 2008; Gosejacob et al., 2011). Because of the dotted
staining pattern of connexins, which makes assignment to specific cells or cell
types difficult or even impossible, reporter genes were useful to study connexin
expression (Requardt et al., 2009; Theis et al., 2005). With double labeling
against the expressed product of a reporter gene and cell-type specific marker
proteins the identity of connexin expressing cells can be clearly identified. An
important prerequisite for the usefulness of reporter genes is their authenticity.
We therefore performed a detailed comparative analysis of hippocampal Cx30
expression using two approaches: (1) Antibodies directed to β-galactosidase
were used for lacZ expression studies of Cx30 gene transcriptional activity
(section 4.4.1 of this thesis); (2) A Cre/loxP-based approach was applied to
monitor transcriptional activity of the Cx30 gene (sections 4.4.2 and 4.4.3 of
this thesis).
The Cx30lacZ allele (Teubner et al., 2003) was used to study Cx30 expres-
sion in the hippocampus with immunohistochemical analysis. The lacZ reporter
gene approach using Cx30lacZ/lacZ mice showed prominent β-galactosidase
expression in the cerebral cortex. Only scattered β-galactosidase immunoreac-
tivity could be detected in the hippocampus of Cx30lacZ/lacZ animals. We
wondered whether Cx30 gene activity was properly reflected by the lacZ re-
porter. As an independent approach to confirm or disconfirm authenticity of
the Cx30lacZ reporter allele, Cx30CreERT2:R26R-EYFP mice were used as
reporter for Cx30 expression. To monitor transcriptional activity of the Cx30
gene, the Cx30CreERT2 BAC transgenic mouse line was used. As readout,
recombination-activation of an EYFP reporter embedded in the ROSA26 locus
was used. The EYFP expression pattern matched the Cx30 expression pattern
determined by Cx30 antibody stainings in the hippocampus. Most importantly
the EYFP expressing cells showed also expression of the astrocytic marker
S100β. Similar results were obtained using astrocytic marker GFAP (Gosejacob
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et al., 2011). Thus, using EYFP expression in the Cx30CreERT2;R26R-EYFP
mice as Cx30 reporter, Cx30 expression was observed predominantly in astro-
cytes.
Our results indicate that the lacZ expression in the Cx30lacZ/lacZ is not
reflect properly Cx30 expression in the hippocampus, even though the Cx30lacZ
allele was generated by homologous recombination and the lacZ reporter gene
is inserted into the Cx30 locus. Disturbance of authentic expression may be
related to the presence of a neomycin resistance cassette in the Cx30lacZ allele
(Teubner et al., 2003). For the hippocampus the Cx30CreERT2 BAC allele
seems to be better suited to study the expression pattern of Cx30. Altogether
Cx30 expression was demonstrated in the hippocampus by immunofluorescence
and immunoblot analysis (Gosejacob et al., 2011) as well as recombination
activation of a reporter gene.
We wanted to assess the relative role of Cx43 an Cx30 in different brain
regions and to quantify the recombination efficacy of the inducible transgenes at
the same time. We observed similar levels of Cx30 and Cx43 expression utilizing
the R26R-EYFP reporter in the cortex and cerebellum. In the barrel cortex,
expression of Cx43 reported by EYFP expression was significantly lower than
in other regions of the somatosensory cortex. No difference in the proportion of
EYFP positive cells was observed in barrels and the septa between the barrels.
Previously, a lower level of connexin expression was reported in the septa in
comparison with the barrels, and reduced astrocytic coupling in the septa was
detected by tracer injection (Houades et al., 2008). The difference to our results
might link at a lower level of Cx43 expression in each cell in the septa, but a
similar proportion of astrocytes expressing Cx43 in barrels and septa.
5.2.1 The role of C43 and 30 in adult neurogenesis
Previously Kunze and colleagues (Kunze et al., 2009) showed the importance of
Cx43 and Cx30 for adult neurogenesis. Mice lacking both connexins (Cx30/Cx43
DKO) showed a significant reduction in the rate of proliferation in the den-
tate gyrus. A reduction in the number of Ki67 (a marker for proliferation)
expressing cells, in the number of Prox1 positive cells (a marker for granule
CHAPTER 5. Discussion 73
cells), and in the number of BrDU labeled cells was observed. From the re-
sults obtained from DKO mice, it is impossible to differentiate effects of Cx30
and Cx43 on neurogenesis. We therefore used Cx43CreERT:R26R-EYFP and
Cx30CreERT2:R26R-EYFP mice for fate mapping studies of Cx43 and Cx30
positive neuronal precursor cells. We analyzed the number of neurons generated
during a one month period, following tamoxifen injection. The number of the
generated neurons, both mature (in the granule cell layer) and immature (in
the subgranular zone) was significantly higher in Cx43CreERT:R26R-EYFP
mice. We also analyzed the number of RG-like cells expressing Cx43 an Cx30
utilizing Cx43CreERT:R26R-EYFP and Cx30CreERT2:R26R-EYFP mice, by
double labeling with BLBP. We observed a significantly higher number of Cx43
positive RG-like cells than Cx30 positive cells. Our results indicate that most
of neuronal precursor cells are Cx43 positive but not Cx30 positive. Similar
results was obtained by Kunze and colleagues (Kunze et al., 2009), by single cell
RT-PCR analysis they revealed that 50% of the RG-like cells express Cx43 and
30 % express Cx30. These findings are in nice correlation with observations of J.
Zhang, who showed a 83% reduction in the number of Ki67-positive cells, and
a 22% reduction in the number of Prox1 positive cells in Cx43 KO mice, but no
such reduction in Cx30 KO mice (J. Zhang unpublished results) From all these
findings, we can conclude that Cx43 is more important for adult neurogenesis
in SGZ than Cx30.
5.3 Quality control of double KO mice
We have observed heterogeneity of hGFAP-Cre mediated recombination, but
the underlying mechanism is still not revealed. Possible influences on the fidelity
of hGFAP-Cre may stem from (i) methylation status (Barresi et al.,1999), (ii)
genetic background, (iii) spontaneous transgene rearrangements (Schulz et al.,
2007), or (iv) other epigenetic mechanisms such as chromatin remodeling (Lee
et al., 2006). Subsequently, possible reproductive deficits in DKO parents may
lead to evolutionary selection against Cre activity. We have presented strategies
assessment of astrocyte-directed DKO mice by immunodetection. Mice could
be analyzed immunostaining for Cre in cerebellum or for β-galactosidase in
CHAPTER 5. Discussion 74
hippocampus. The same mice could be analyzed utilizing immunobloting or
PCR technique (Requardt et al., 2009). The deletion status of DKO mice
was consistent within breedings. Thus, the procedures described here allow
pre-experimental assessment of siblings in order to estimate the activity status
of Cre within a litter. Although we found a strong consistency of Cre deletion
status among siblings, we nevertheless recommend postexperimental evaluation
of individual mice to correlate the gene inactivation status with phenotypical
alterations.
5.4 Quality control of Cx43CreERT:R26R-EYFP
We observed spontaneous recombination (background recombination without
induction by tamoxifen injection) in Cx43CreERT:R26R-EYFP mice. but not
in Cx30CreERT2:R26R-EYFP mice. In these mice different types of inducible
Cre are expressed: in Cx43CreERT:R26R-EYFP mice, CreERT1 (Feil et al.,
1996) is expressed and in Cx30CreERT2:R26R-EYFP mice, CreERT2 (Feil
et al., 1997) is expressed. For both types of CreERT background recombination
was previously reported (Kemp et al., 2004; Hameyer et al., 2007; Matsuda &
Cepko, 2007). The background recombination in Cx43CreERT mice is higher
most probably because of higher levels of Cx43CreERT expression (higher level
of expression results in higher level of background recombination; Joyner &
Sudarov, 2011).
This background recombination could be detected easily by PCR analysis
of tail tip DNA. Since Cx43CreERT:R26R-EYFP mice show background re-
combination and higher variability in expression levels in the different brain
regions, and higher numbers of EYFP expressing neurons because of Cx43
expression in stem cells, Cx30CreERT2:R26R-EYFP mice are more suitable
for fate mapping studies in astrocytes.
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5.5 DKO mice in epilepsy
In control mice subjected to TLE model we observed neuronal cell loss in CA1
region, granule cell dispersion, similar morphological changes were observed
in TLE patients (Armstrong, 1993). We also observed loss of NeuN related
immunoreactivity in the dentate gyrus, while neurones were still visible on the
Hoechst staining. Loss of NeuN immunoreactivity without neuronal loss was
observed previously under different pathological conditions: transient reduc-
tion of NeuN after axototomy (McPhail et al., 2004) and permanent loss in
cerebrall ischemia (Unal-Cevik et al., 2004). This loss of NeuN immunoreac-
tivity was accompanied by a reduction in immunoreactivity of other neuron
specific proteins as choline acetyl transferase (ChAT; McPhail et al., 2004)
and microtubule-associated protein-2 (MAP-2; Chen et al., 2001), and may
be associated with reduction of the protein synthesis or increase in protein
degradation under pathological conditions (Unal-Cevik et al., 2004).
In DKO animals, morphological changes in the TLE model were less pro-
nounced, i.e. AHS was less severe. At the same time, these animal showed a
shorter status epilepticus after kainate injection (Peter Bedner, unpublished
results). These findings could be a result of a reduction in glutamatergic
synaptic transmission and neuronal activity due to decreased metabolite supply
to neurones by the astrocytic network, due to loss of astrocytic gap junctional
coupling (Rouach et al., 2008). Less pronounced morphological changes indi-
cated a pro-epileptic function of astrocytic gap junctions. DKO mice however,
showed a shorter latency period and higher number of spontaneous seizures
indicating an anti-epileptic functions of astrocytic gap junctions, as well. This
anti-epileptic function might be linked to reduction of neuronal excitability by
a mechanism of the spatial buffering of K+ (Wallraff et al., 2006). Another
study recently showed that in DKO mice lacking Cx43 and Cx30 neuronal
excitability is increased (Pannasch et al., 2011). This led us to the following
working hypothesis: immediately after kainate injection, i.e. in status epilepti-
cus metabolite supply may be the predominant function of astrocytic connexins
supporting neuronal hyperexcitability. However, during the chronic phase,
removal of the K+ by a mechanism of spatial buffering may be the predominant
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function of astrocytic connexins, which limits neuronal activity.
5.6 Fate mapping of astrocytes in TLE
In the hippocampi of patients suffering from TLE, almost complete loss of
”bona fida” astrocytes showing passive currents and coupling by gap junc-
tions was observed (Bedner et al., unpublished), while most of the remain-
ing glial cells showed properties of NG2 glial cells. We decided to inves-
tigate the fate of the astrocytes, i.e. if they transdifferentiate into NG2
glial cells, or if they just die. First, we established a model for astrocytic
fate mapping in vivo. We analyzed four different transgenic mouse models
(GFAPCreERT:R26R, GLASTCreERT:Cx43fl(LacZ), Cx30CreERT2:R26R-
EYFP, and Cx43CreERT:R26R-EYFP with different paradigms of tamoxifen
and hydroxytamoxifen injection. Cx30CreER:R26R-EYFP and Cx43CreERT:
R26R-EYFP mice showed highest levels of recombination in astrocytes, and
they were found suitable for fate mapping of astrocytes in the TLE model. No
EYFP expression was observed in NG2 glia (detected by immunofluorescence)
in the hippocampus of Cx43CreERT:R26R-EYFP mice up to 6 month after
kainate injection. At this time point, morphological changes in hippocampus
were already very pronounced (see Fig. 4.8), and EYFP positive cells showed a
current pattern untypical for astrocytes (Bedner et al., unpublished). Most of
the EYFP positive cells were also GFAP positive. Some of the EYFP positive
cells were neither NG2 nor GFAP positive. Part of these cells exhibited a non-
astrocytic morphology, but a precise determination of these cells needs further
investigation. Taking all findings together, we can conclude that astrocytes in
TLE do not transdifferentiate into NG2 cells.
77
Summary
Despite of the growing number of studies, the expression pattern as well as the
exact functions of astrocytic connexins are not yet fully elucidated. In this study I
analyzed the expression pattern and functions of the two major astrocytic connexins,
Cx30 and Cx43, under normal conditions and in a mouse model for temporal lobe
epilepsy (TLE).
In the first part of my work I characterized novel conditional knock out mice,
expressing ECFP instead of Cx43 after Cre-mediated recombination. Utilizing
this mouse, I demonstrated dual reporter approaches to i) simultaneously examine
astrocyte subpopulations expressing different connexins, ii) identify compensatory
upregulation within gene families and iii) quantify Cre-mediated deletion at the
allelic level.
In the second part of my work, I re-evaluated the expression of Cx30 in different
brain regions. I analyzed the reporter gene expression of Cx30 knockout mice.
Utilizing a fate mapping approach, I showed that the reporter gene expression does
not reflect properly the Cx30 expression in the hippocampus. Using a fate mapping
approach, I also demonstrated that Cx30 is expressed at similar levels compared to
Cx43 in most brain regions. In addition, utilizing the same fate mapping approach,
I showed that radial glia like cells express mostly Cx43, indicating that Cx43 is the
most important connexin for adult neurogenesis.
In the third part of my work, I analyzed the influence of Cx30 and Cx43 on
morphological changes in brain of mice subjected to a novel mouse TLE model
(intracortical kainate injection). In mice lacking both Cx43 and Cx30, I observed
less pronounced morphological changes in the hippocampus. I also established
methods for quality control of the trangenic mice used in this study. My study
adds to a better understanding of expression pattern of astrocytic connexines in
the brain, and its role in the epilepsy.
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